%% This BibTeX bibliography file was created using BibDesk.
%% http://bibdesk.sourceforge.net/


%% Created for Kathy Rogers at 2016-01-06 18:33:00 -0500 


%% Saved with string encoding Unicode (UTF-8) 



@article{Iadevaia2010,
	Abstract = {Targeted therapeutics hold tremendous promise in inhibiting cancer cell proliferation. However, targeting proteins individually can be compensated for by bypass mechanisms and activation of regulatory loops. Designing optimal therapeutic combinations must therefore take into consideration the complex dynamic networks in the cell. In this study, we analyzed the insulin-like growth factor (IGF-1) signaling network in the MDA-MB231 breast cancer cell line. We used reverse-phase protein array to measure the transient changes in the phosphorylation of proteins after IGF-1 stimulation. We developed a computational procedure that integrated mass action modeling with particle swarm optimization to train the model against the experimental data and infer the unknown model parameters. The trained model was used to predict how targeting individual signaling proteins altered the rest of the network and identify drug combinations that minimally increased phosphorylation of other proteins elsewhere in the network. Experimental testing of the modeling predictions showed that optimal drug combinations inhibited cell signaling and proliferation, whereas nonoptimal combination of inhibitors increased phosphorylation of nontargeted proteins and rescued cells from cell death. The integrative approach described here is useful for generating experimental intervention strategies that could optimize drug combinations and discover novel pharmacologic targets for cancer therapy.},
	Author = {Iadevaia, Sergio and Lu, Yiling and Morales, Fabiana C and Mills, Gordon B and Ram, Prahlad T},
	Date-Added = {2016-01-06 23:32:58 +0000},
	Date-Modified = {2016-01-06 23:32:58 +0000},
	Doi = {10.1158/0008-5472.CAN-10-0460},
	Journal = {Cancer Res},
	Journal-Full = {Cancer research},
	Mesh = {Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Insulin-Like Growth Factor I; MAP Kinase Signaling System; Models, Biological; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Array Analysis; Proteomics; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Signal Transduction},
	Month = {Sep},
	Number = {17},
	Pages = {6704-14},
	Pmc = {PMC2932856},
	Pmid = {20643779},
	Pst = {ppublish},
	Title = {Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis},
	Volume = {70},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1158/0008-5472.CAN-10-0460}}

@article{Keith2005,
	Abstract = {Therapeutic regimens that comprise more than one active ingredient are commonly used in clinical medicine. Despite this, most drug discovery efforts search for drugs that are composed of a single chemical entity. A focus in the early drug discovery process on identifying and optimizing the activity of combinations of molecules can result in the identification of more effective drug regimens. A systems perspective facilitates an understanding of the mechanism of action of such drug combinations.},
	Author = {Keith, Curtis T and Borisy, Alexis A and Stockwell, Brent R},
	Date-Added = {2016-01-06 23:32:55 +0000},
	Date-Modified = {2016-01-06 23:32:55 +0000},
	Doi = {10.1038/nrd1609},
	Journal = {Nat Rev Drug Discov},
	Journal-Full = {Nature reviews. Drug discovery},
	Mesh = {Clinical Trials as Topic; Drug Design; Drug Synergism; Drug Therapy, Combination; Humans; Terminology as Topic},
	Month = {Jan},
	Number = {1},
	Pages = {71-8},
	Pmid = {15688074},
	Pst = {ppublish},
	Title = {Multicomponent therapeutics for networked systems},
	Volume = {4},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nrd1609}}

@article{Kauffman1969,
	Author = {Kauffman, S A},
	Date-Added = {2016-01-06 23:32:49 +0000},
	Date-Modified = {2016-01-06 23:32:49 +0000},
	Journal = {J Theor Biol},
	Journal-Full = {Journal of theoretical biology},
	Mesh = {Animals; Anura; Cattle; Cell Differentiation; Cell Division; DNA Replication; Dogs; Genes; Humans; Metabolism; Mice; Models, Theoretical; Molecular Biology; Periodicity; Rats},
	Month = {Mar},
	Number = {3},
	Pages = {437-67},
	Pmid = {5803332},
	Pst = {ppublish},
	Title = {Metabolic stability and epigenesis in randomly constructed genetic nets},
	Volume = {22},
	Year = {1969}}

@article{Zhang2008,
	Abstract = {T cell large granular lymphocyte (T-LGL) leukemia features a clonal expansion of antigen-primed, competent, cytotoxic T lymphocytes (CTL). To systematically understand signaling components that determine the survival of CTL in T-LGL leukemia, we constructed a T-LGL survival signaling network by integrating the signaling pathways involved in normal CTL activation and the known deregulations of survival signaling in leukemic T-LGL. This network was subsequently translated into a predictive, discrete, dynamic model. Our model suggests that the persistence of IL-15 and PDGF is sufficient to reproduce all known deregulations in leukemic T-LGL. This finding leads to the following predictions: (i) Inhibiting PDGF signaling induces apoptosis in leukemic T-LGL. (ii) Sphingosine kinase 1 and NFkappaB are essential for the long-term survival of CTL in T-LGL leukemia. (iii) NFkappaB functions downstream of PI3K and prevents apoptosis through maintaining the expression of myeloid cell leukemia sequence 1. (iv) T box expressed in T cells (T-bet) should be constitutively activated concurrently with NFkappaB activation to reproduce the leukemic T-LGL phenotype. We validated these predictions experimentally. Our study provides a model describing the signaling network involved in maintaining the long-term survival of competent CTL in humans. The model will be useful in identifying potential therapeutic targets for T-LGL leukemia and generating long-term competent CTL necessary for tumor and cancer vaccine development.},
	Author = {Zhang, Ranran and Shah, Mithun Vinod and Yang, Jun and Nyland, Susan B and Liu, Xin and Yun, Jong K and Albert, R{\'e}ka and Loughran, Jr, Thomas P},
	Date-Added = {2016-01-06 23:30:33 +0000},
	Date-Modified = {2016-01-06 23:30:33 +0000},
	Doi = {10.1073/pnas.0806447105},
	Journal = {Proc Natl Acad Sci U S A},
	Journal-Full = {Proceedings of the National Academy of Sciences of the United States of America},
	Mesh = {Adaptor Proteins, Signal Transducing; Humans; Interleukin-15; Leukemia, Large Granular Lymphocytic; Models, Biological; NF-kappa B; Platelet-Derived Growth Factor; STAT3 Transcription Factor; Signal Transduction; Tumor Cells, Cultured},
	Month = {Oct},
	Number = {42},
	Pages = {16308-13},
	Pmc = {PMC2571012},
	Pmid = {18852469},
	Pst = {ppublish},
	Title = {Network model of survival signaling in large granular lymphocyte leukemia},
	Volume = {105},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1073/pnas.0806447105}}

@article{Yarden2001,
	Abstract = {When epidermal growth factor and its relatives bind the ErbB family of receptors, they trigger a rich network of signalling pathways, culminating in responses ranging from cell division to death, motility to adhesion. The network is often dysregulated in cancer and lends credence to the mantra that molecular understanding yields clinical benefit: over 25,000 women with breast cancer have now been treated with trastuzumab (Herceptin), a recombinant antibody designed to block the receptor ErbB2. Likewise, small-molecule enzyme inhibitors and monoclonal antibodies to ErbB1 are in advanced phases of clinical testing. What can this pathway teach us about translating basic science into clinical use?},
	Author = {Yarden, Y and Sliwkowski, M X},
	Date-Added = {2016-01-06 23:29:57 +0000},
	Date-Modified = {2016-01-06 23:29:57 +0000},
	Doi = {10.1038/35052073},
	Journal = {Nat Rev Mol Cell Biol},
	Journal-Full = {Nature reviews. Molecular cell biology},
	Mesh = {Animals; Neoplasms; Receptor, erbB-2; Signal Transduction},
	Month = {Feb},
	Number = {2},
	Pages = {127-37},
	Pmid = {11252954},
	Pst = {ppublish},
	Title = {Untangling the ErbB signalling network},
	Volume = {2},
	Year = {2001},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/35052073}}

@article{Wiley2003,
	Abstract = {Computational models have rarely been used as tools by biologists but, when models provide experimentally testable predictions, they can be extremely useful. The epidermal growth factor receptor (EGFR) is probably the best-understood receptor system, and computational models have played a significant part in its elucidation. For many years, models have been used to analyze EGFR dynamics and to interpret mutational studies, and are now being used to understand processes including signal transduction, autocrine loops and developmental patterning. The success of EGFR modeling can be a guide to combining models and experiments productively to understand complex biological processes as integrated systems.},
	Author = {Wiley, H Steven and Shvartsman, Stanislav Y and Lauffenburger, Douglas A},
	Date-Added = {2016-01-06 23:29:25 +0000},
	Date-Modified = {2016-01-06 23:29:25 +0000},
	Journal = {Trends Cell Biol},
	Journal-Full = {Trends in cell biology},
	Mesh = {Animals; Computational Biology; Humans; Models, Biological; Protein Binding; Receptor, Epidermal Growth Factor; Signal Transduction},
	Month = {Jan},
	Number = {1},
	Pages = {43-50},
	Pmid = {12480339},
	Pst = {ppublish},
	Title = {Computational modeling of the EGF-receptor system: a paradigm for systems biology},
	Volume = {13},
	Year = {2003}}

@article{Wang2009,
	Abstract = {We present a multiscale agent-based non-small cell lung cancer model that consists of a 3D environment with which cancer cells interact while processing phenotypic changes. At the molecular level, transforming growth factor beta (TGFbeta) has been integrated into our previously developed in silico model as a second extrinsic input in addition to epidermal growth factor (EGF). The main aim of this study is to investigate how the effects of individual and combinatorial change in EGF and TGFbeta concentrations at the molecular level alter tumor growth dynamics on the multi-cellular level, specifically tumor volume and expansion rate. Our simulation results show that separate EGF and TGFbeta fluctuations trigger competing multi-cellular phenotypes, yet synchronous EGF and TGFbeta signaling yields a spatially more aggressive tumor that overall exhibits an EGF-driven phenotype. By altering EGF and TGFbeta concentration levels simultaneously and asynchronously, we discovered a particular region of EGF-TGFbeta profiles that ensures phenotypic stability of the tumor system. Within this region, concentration changes in EGF and TGFbeta do not impact the resulting multi-cellular response substantially, while outside these concentration ranges, a change at the molecular level will substantially alter either tumor volume or tumor expansion rate, or both. By evaluating tumor growth dynamics across different scales, we show that, under certain conditions, therapeutic targeting of only one signaling pathway may be insufficient. Potential implications of these in silico results for future clinico-pharmacological applications are discussed.},
	Author = {Wang, Zhihui and Birch, Christina M and Sagotsky, Jonathan and Deisboeck, Thomas S},
	Date-Added = {2016-01-06 23:28:36 +0000},
	Date-Modified = {2016-01-06 23:28:36 +0000},
	Doi = {10.1093/bioinformatics/btp416},
	Journal = {Bioinformatics},
	Journal-Full = {Bioinformatics (Oxford, England)},
	Mesh = {Computational Biology; Epidermal Growth Factor; Lung Neoplasms; Signal Transduction; Transforming Growth Factor beta},
	Month = {Sep},
	Number = {18},
	Pages = {2389-96},
	Pmc = {PMC2735669},
	Pmid = {19578172},
	Pst = {ppublish},
	Title = {Cross-scale, cross-pathway evaluation using an agent-based non-small cell lung cancer model},
	Volume = {25},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/bioinformatics/btp416}}

@article{Vera2008,
	Abstract = {BACKGROUND: The amplification of signals, defined as an increase in the intensity of a signal through networks of intracellular reactions, is considered one of the essential properties in many cell signalling pathways. Despite of the apparent importance of signal amplification, there have been few attempts to formalise this concept.
RESULTS: In this work we investigate the amplification and responsiveness of the JAK2-STAT5 pathway using a kinetic model. The recruitment of EpoR to the plasma membrane, activation by Epo, and deactivation of the EpoR/JAK2 complex are considered as well as the activation and nucleocytoplasmic shuttling of STAT5. Using qualitative biological knowledge, we first establish the structure of a general power-law model. We then generate a family of models from which we select suitable candidates. The parameter values of the model are estimated from experimental quantitative time-course data. The final model, whether it is conventional model with fixed predefined integer kinetic orders or a model with variable non-integer kinetic orders, is selected on the basis of a good agreement between simulations and the experimental data. The model is used to analyse the responsiveness and amplification properties of the pathway with sustained, transient, and oscillatory stimulation.
CONCLUSION: The selected kinetic model predicts that the system acts as an amplifier with maximum amplification and sensitivity for input signals whose intensity match physiological values for Epo concentration and with duration in the range of one to 100 minutes. The response of the system reaches saturation for more intense and longer stimulation with Epo. We hypothesise that these properties of the system directly relate to the saturation of Epo receptor activation, its low recruitment to the plasma membrane and intense deactivation as predicted by the model.},
	Author = {Vera, Julio and Bachmann, Julie and Pfeifer, Andrea C and Becker, Verena and Hormiga, Jose A and Darias, Nestor V Torres and Timmer, Jens and Klingm{\"u}ller, Ursula and Wolkenhauer, Olaf},
	Date-Added = {2016-01-06 23:27:56 +0000},
	Date-Modified = {2016-01-06 23:27:56 +0000},
	Doi = {10.1186/1752-0509-2-38},
	Journal = {BMC Syst Biol},
	Journal-Full = {BMC systems biology},
	Mesh = {Active Transport, Cell Nucleus; Animals; Binding Sites; Cell Line, Transformed; Cell Nucleus; Erythropoietin; Humans; Janus Kinase 2; Kinetics; Mice; Models, Biological; Predictive Value of Tests; Receptors, Erythropoietin; STAT5 Transcription Factor; Signal Transduction; Systems Biology; Time Factors},
	Pages = {38},
	Pmc = {PMC2386439},
	Pmid = {18439261},
	Pst = {epublish},
	Title = {A systems biology approach to analyse amplification in the JAK2-STAT5 signalling pathway},
	Volume = {2},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/1752-0509-2-38}}

@article{Vanneman2012,
	Abstract = {During the past two decades, the paradigm for cancer treatment has evolved from relatively nonspecific cytotoxic agents to selective, mechanism-based therapeutics. Cancer chemotherapies were initially identified through screens for compounds that killed rapidly dividing cells. These drugs remain the backbone of current treatment, but they are limited by a narrow therapeutic index, significant toxicities and frequently acquired resistance. More recently, an improved understanding of cancer pathogenesis has given rise to new treatment options, including targeted agents and cancer immunotherapy. Targeted approaches aim to inhibit molecular pathways that are crucial for tumour growth and maintenance; whereas, immunotherapy endeavours to stimulate a host immune response that effectuates long-lived tumour destruction. Targeted therapies and cytotoxic agents also modulate immune responses, which raises the possibility that these treatment strategies might be effectively combined with immunotherapy to improve clinical outcomes.},
	Author = {Vanneman, Matthew and Dranoff, Glenn},
	Date-Added = {2016-01-06 23:27:01 +0000},
	Date-Modified = {2016-01-06 23:27:01 +0000},
	Doi = {10.1038/nrc3237},
	Journal = {Nat Rev Cancer},
	Journal-Full = {Nature reviews. Cancer},
	Mesh = {Animals; Antigen Presentation; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Clinical Trials as Topic; Humans; Immunomodulation; Immunotherapy; Molecular Targeted Therapy; Neoplasms},
	Month = {Apr},
	Number = {4},
	Pages = {237-51},
	Pmid = {22437869},
	Pst = {epublish},
	Title = {Combining immunotherapy and targeted therapies in cancer treatment},
	Volume = {12},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nrc3237}}

@article{Tasseff2010,
	Abstract = {Androgen ablation therapy is currently the primary treatment for metastatic prostate cancer. Unfortunately, in nearly all cases, androgen ablation fails to permanently arrest cancer progression. As androgens like testosterone are withdrawn, prostate cancer cells lose their androgen sensitivity and begin to proliferate without hormone growth factors. In this study, we constructed and analyzed a mathematical model of the integration between hormone growth factor signaling, androgen receptor activation, and the expression of cyclin D and Prostate-Specific Antigen in human LNCaP prostate adenocarcinoma cells. The objective of the study was to investigate which signaling systems were important in the loss of androgen dependence. The model was formulated as a set of ordinary differential equations which described 212 species and 384 interactions, including both the mRNA and protein levels for key species. An ensemble approach was chosen to constrain model parameters and to estimate the impact of parametric uncertainty on model predictions. Model parameters were identified using 14 steady-state and dynamic LNCaP data sets taken from literature sources. Alterations in the rate of Prostatic Acid Phosphatase expression was sufficient to capture varying levels of androgen dependence. Analysis of the model provided insight into the importance of network components as a function of androgen dependence. The importance of androgen receptor availability and the MAPK/Akt signaling axes was independent of androgen status. Interestingly, androgen receptor availability was important even in androgen-independent LNCaP cells. Translation became progressively more important in androgen-independent LNCaP cells. Further analysis suggested a positive synergy between the MAPK and Akt signaling axes and the translation of key proliferative markers like cyclin D in androgen-independent cells. Taken together, the results support the targeting of both the Akt and MAPK pathways. Moreover, the analysis suggested that direct targeting of the translational machinery, specifically eIF4E, could be efficacious in androgen-independent prostate cancers.},
	Author = {Tasseff, Ryan and Nayak, Satyaprakash and Salim, Saniya and Kaushik, Poorvi and Rizvi, Noreen and Varner, Jeffrey D},
	Date-Added = {2016-01-06 23:26:04 +0000},
	Date-Modified = {2016-01-06 23:26:04 +0000},
	Doi = {10.1371/journal.pone.0008864},
	Journal = {PLoS One},
	Journal-Full = {PloS one},
	Mesh = {Androgens; Cell Line, Tumor; Cyclin D; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms},
	Number = {1},
	Pages = {e8864},
	Pmc = {PMC2812491},
	Pmid = {20126616},
	Pst = {epublish},
	Title = {Analysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems},
	Volume = {5},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pone.0008864}}

@article{Swanson2003,
	Author = {Swanson, Kristin R and True, Lawrence D and Murray, J D},
	Date-Added = {2016-01-06 23:25:15 +0000},
	Date-Modified = {2016-01-06 23:25:15 +0000},
	Doi = {10.1309/AR06-82JH-8B1B-G058},
	Journal = {Am J Clin Pathol},
	Journal-Full = {American journal of clinical pathology},
	Mesh = {Anti-HIV Agents; Brain Neoplasms; Drug Therapy, Combination; Glioma; HIV Infections; Humans; Male; Models, Biological; Neoplasm Invasiveness; Prostate-Specific Antigen; Prostatic Neoplasms},
	Month = {Jan},
	Number = {1},
	Pages = {14-7},
	Pmid = {12520692},
	Pst = {ppublish},
	Title = {On the use of quantitative modeling to help understand prostate-specific antigen dynamics and other medical problems},
	Volume = {119},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1309/AR06-82JH-8B1B-G058}}

@article{Swameye2003,
	Abstract = {Considerable progress has been made in identifying the molecular composition of complex signaling networks controlling cell proliferation, differentiation, and survival. However, to discover general building principles and predict the dynamic behavior of signaling networks, it is necessary to develop quantitative models based on experimental observations. Here we report a mathematical model of the core module of the Janus family of kinases (JAK)-signal transducer and activator of transcription (STAT) signaling pathway based on time-resolved measurements of receptor and STAT5 phosphorylation. Applying the fitted model, we can determine the quantitative behavior of STAT5 populations not accessible to experimental measurement. By in silico investigations, we identify the parameters of nuclear shuttling as the most sensitive to perturbations and verify experimentally the model prediction that inhibition of nuclear export results in a reduced transcriptional yield. The model reveals that STAT5 undergoes rapid nucleocytoplasmic cycles, continuously coupling receptor activation and target gene transcription, thereby forming a remote sensor between nucleus and receptor. Thus, dynamic modeling of signaling pathways can promote functional understanding at the systems level.},
	Author = {Swameye, I and Muller, T G and Timmer, J and Sandra, O and Klingmuller, U},
	Date-Added = {2016-01-06 23:25:04 +0000},
	Date-Modified = {2016-01-06 23:25:04 +0000},
	Doi = {10.1073/pnas.0237333100},
	Journal = {Proc Natl Acad Sci U S A},
	Journal-Full = {Proceedings of the National Academy of Sciences of the United States of America},
	Mesh = {Animals; Cell Differentiation; Cell Division; Cell Line; Cell Nucleus; Cell Survival; Computer Simulation; Cytoplasm; DNA-Binding Proteins; Databases as Topic; Mice; Milk Proteins; Models, Biological; Models, Theoretical; Protein Transport; STAT5 Transcription Factor; Signal Transduction; Time Factors; Trans-Activators; Transcription, Genetic; beta-Galactosidase},
	Month = {Feb},
	Number = {3},
	Pages = {1028-33},
	Pmc = {PMC298720},
	Pmid = {12552139},
	Pst = {ppublish},
	Title = {Identification of nucleocytoplasmic cycling as a remote sensor in cellular signaling by databased modeling},
	Volume = {100},
	Year = {2003},
	Bdsk-Url-1 = {http://dx.doi.org/10.1073/pnas.0237333100}}

@article{Starbuck1992,
	Abstract = {We apply a mathematical model for receptor-mediated cell uptake and processing of epidermal growth factor (EGF) to analyze and predict proliferation responses to fibroblastic cells transfected with various forms of the EGF receptor (EGFR) to EGF. The underlying conceptual hypothesis is that the mitogenic signal generated by EGF/EGFR binding on the cell surface, via stimulation of receptor tyrosine kinase activity, is attenuated when the receptors are downregulated and growth factor is depleted by endocytic internalization and subsequent intracellular degradation. Hence, the cell proliferation rate ought to depend on receptor/ligand binding and trafficking parameters as well as on intrinsic receptor signal transduction properties. The goal of our modeling efforts is to formulate this hypothesis in quantitative terms. The mathematical model consists of kinetic equations for binding, internalization, degradation, and recycling of EGF and EGFR, along with an expression relating DNA synthesis rate to EGF/EGFR complex levels. Parameter values have been previously determined from independent binding and trafficking kinetic experiments on B82 fibroblasts transfected with wild-type and mutant EGFR. We show that this model can successfully interpret literature data for EGF-dependent growth of NR6 fibroblasts transfected with wild-type EGFR. Moreover, it successfully predicts the literature observation that NR6 cells transfected with a delta 973 truncation mutant EGFR, which is kinase-active but internalization-deficient, require an order of magnitude lower EGF concentration than cells with wild-type EGFR for half-maximal proliferation rate. This result demonstrates that it may be feasible to genetically engineer mammalian cell lines with reduced growth factor requirements by a rational, nonempirical approach. We explore by further model computations the possibility of exploiting other varieties of EGFR mutants to alter growth properties of fibroblastic cells, based on relationships between changes in the primary structure of the EGF receptor and the rates of specific receptor/ligand binding and trafficking processes. Our studies show that the ability to predict cell proliferation as a function of serum growth factors such as EGF could lead to the designed development of cells with optimized growth responses. This approach may also aid in elucidation of mechanisms underlying loss of normal cell proliferation control in malignant transformation, by demonstrating that receptor trafficking dynamics may in some cases play as important a role as intrinsic signal transduction in determining the overall resulting mitogenic response.},
	Author = {Starbuck, C and Lauffenburger, D A},
	Date = {1992 Mar-Apr},
	Date-Added = {2016-01-06 23:24:42 +0000},
	Date-Modified = {2016-01-06 23:24:42 +0000},
	Doi = {10.1021/bp00014a007},
	Journal = {Biotechnol Prog},
	Journal-Full = {Biotechnology progress},
	Mesh = {Cell Division; DNA; Epidermal Growth Factor; Fibroblasts; Kinetics; Mathematics; Models, Biological; Receptor, Epidermal Growth Factor; Transfection},
	Number = {2},
	Pages = {132-43},
	Pmid = {1368006},
	Pst = {ppublish},
	Title = {Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses},
	Volume = {8},
	Year = {1992},
	Bdsk-Url-1 = {http://dx.doi.org/10.1021/bp00014a007}}

@article{Song2010,
	Abstract = {Mathematical modeling of complex gene expression programs is an emerging tool for understanding disease mechanisms. However, identification of large models sometimes requires training using qualitative, conflicting or even contradictory data sets. One strategy to address this challenge is to estimate experimentally constrained model ensembles using multiobjective optimization. In this study, we used Pareto Optimal Ensemble Techniques (POETs) to identify a family of proof-of-concept signal transduction models. POETs integrate Simulated Annealing (SA) with Pareto optimality to identify models near the optimal tradeoff surface between competing training objectives. We modeled a prototypical-signaling network using mass-action kinetics within an ordinary differential equation (ODE) framework (64 ODEs in total). The true model was used to generate synthetic immunoblots from which the POET algorithm identified the 117 unknown model parameters. POET generated an ensemble of signaling models, which collectively exhibited population-like behavior. For example, scaled gene expression levels were approximately normally distributed over the ensemble following the addition of extracellular ligand. Also, the ensemble recovered robust and fragile features of the true model, despite significant parameter uncertainty. Taken together, these results suggest that experimentally constrained model ensembles could capture qualitatively important network features without exact parameter information.},
	Author = {Song, Sang Ok and Chakrabarti, Anirikh and Varner, Jeffrey D},
	Date-Added = {2016-01-06 23:24:11 +0000},
	Date-Modified = {2016-01-06 23:24:11 +0000},
	Doi = {10.1002/biot.201000059},
	Journal = {Biotechnol J},
	Journal-Full = {Biotechnology journal},
	Mesh = {Algorithms; Models, Biological; Signal Transduction; Systems Biology},
	Month = {Jul},
	Number = {7},
	Pages = {768-80},
	Pmc = {PMC3021968},
	Pmid = {20665647},
	Pst = {ppublish},
	Title = {Ensembles of signal transduction models using Pareto Optimal Ensemble Techniques (POETs)},
	Volume = {5},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1002/biot.201000059}}

@article{Sklar2007,
	Author = {Sklar, Elizabeth},
	Date-Added = {2016-01-06 23:23:52 +0000},
	Date-Modified = {2016-01-06 23:23:52 +0000},
	Doi = {10.1162/artl.2007.13.3.303},
	Journal = {Artif Life},
	Journal-Full = {Artificial life},
	Mesh = {Algorithms; Artificial Intelligence; Communication; Computer Simulation; Models, Theoretical; Software},
	Number = {3},
	Pages = {303-11},
	Pmid = {17567250},
	Pst = {ppublish},
	Title = {NetLogo, a multi-agent simulation environment},
	Volume = {13},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1162/artl.2007.13.3.303}}

@article{Schoeberl2002,
	Abstract = {We present a computational model that offers an integrated quantitative, dynamic, and topological representation of intracellular signal networks, based on known components of epidermal growth factor (EGF) receptor signal pathways. The model provides insight into signal-response relationships between the binding of EGF to its receptor at the cell surface and the activation of downstream proteins in the signaling cascade. It shows that EGF-induced responses are remarkably stable over a 100-fold range of ligand concentration and that the critical parameter in determining signal efficacy is the initial velocity of receptor activation. The predictions of the model agree well with experimental analysis of the effect of EGF on two downstream responses, phosphorylation of ERK-1/2 and expression of the target gene, c-fos.},
	Author = {Schoeberl, Birgit and Eichler-Jonsson, Claudia and Gilles, Ernst Dieter and M{\"u}ller, Gertraud},
	Date-Added = {2016-01-06 23:10:20 +0000},
	Date-Modified = {2016-01-06 23:10:20 +0000},
	Doi = {10.1038/nbt0402-370},
	Journal = {Nat Biotechnol},
	Journal-Full = {Nature biotechnology},
	Mesh = {Computational Biology; Computer Simulation; Down-Regulation; Endocytosis; Enzyme Activation; Epidermal Growth Factor; Genes, fos; HeLa Cells; Humans; Kinetics; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Models, Biological; Receptor, Epidermal Growth Factor; Software},
	Month = {Apr},
	Number = {4},
	Pages = {370-5},
	Pmid = {11923843},
	Pst = {ppublish},
	Title = {Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors},
	Volume = {20},
	Year = {2002},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nbt0402-370}}

@article{Schoeberl2009,
	Abstract = {The signaling network downstream of the ErbB family of receptors has been extensively targeted by cancer therapeutics; however, understanding the relative importance of the different components of the ErbB network is nontrivial. To explore the optimal way to therapeutically inhibit combinatorial, ligand-induced activation of the ErbB-phosphatidylinositol 3-kinase (PI3K) axis, we built a computational model of the ErbB signaling network that describes the most effective ErbB ligands, as well as known and previously unidentified ErbB inhibitors. Sensitivity analysis identified ErbB3 as the key node in response to ligands that can bind either ErbB3 or EGFR (epidermal growth factor receptor). We describe MM-121, a human monoclonal antibody that halts the growth of tumor xenografts in mice and, consistent with model-simulated inhibitor data, potently inhibits ErbB3 phosphorylation in a manner distinct from that of other ErbB-targeted therapies. MM-121, a previously unidentified anticancer therapeutic designed using a systems approach, promises to benefit patients with combinatorial, ligand-induced activation of the ErbB signaling network that are not effectively treated by current therapies targeting overexpressed or mutated oncogenes.},
	Author = {Schoeberl, Birgit and Pace, Emily A and Fitzgerald, Jonathan B and Harms, Brian D and Xu, Lihui and Nie, Lin and Linggi, Bryan and Kalra, Ashish and Paragas, Violette and Bukhalid, Raghida and Grantcharova, Viara and Kohli, Neeraj and West, Kip A and Leszczyniecka, Magdalena and Feldhaus, Michael J and Kudla, Arthur J and Nielsen, Ulrik B},
	Date-Added = {2016-01-06 23:10:14 +0000},
	Date-Modified = {2016-01-06 23:10:14 +0000},
	Doi = {10.1126/scisignal.2000352},
	Journal = {Sci Signal},
	Journal-Full = {Science signaling},
	Mesh = {Animals; Antibodies, Monoclonal; Humans; Ligands; Mice; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Binding; Receptor, Epidermal Growth Factor; Receptor, erbB-3; Signal Transduction; Transplantation, Heterologous},
	Number = {77},
	Pages = {ra31},
	Pmid = {19567914},
	Pst = {epublish},
	Title = {Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis},
	Volume = {2},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1126/scisignal.2000352}}

@article{Samaga2009,
	Abstract = {The epidermal growth factor receptor (EGFR) signaling pathway is probably the best-studied receptor system in mammalian cells, and it also has become a popular example for employing mathematical modeling to cellular signaling networks. Dynamic models have the highest explanatory and predictive potential; however, the lack of kinetic information restricts current models of EGFR signaling to smaller sub-networks. This work aims to provide a large-scale qualitative model that comprises the main and also the side routes of EGFR/ErbB signaling and that still enables one to derive important functional properties and predictions. Using a recently introduced logical modeling framework, we first examined general topological properties and the qualitative stimulus-response behavior of the network. With species equivalence classes, we introduce a new technique for logical networks that reveals sets of nodes strongly coupled in their behavior. We also analyzed a model variant which explicitly accounts for uncertainties regarding the logical combination of signals in the model. The predictive power of this model is still high, indicating highly redundant sub-structures in the network. Finally, one key advance of this work is the introduction of new techniques for assessing high-throughput data with logical models (and their underlying interaction graph). By employing these techniques for phospho-proteomic data from primary hepatocytes and the HepG2 cell line, we demonstrate that our approach enables one to uncover inconsistencies between experimental results and our current qualitative knowledge and to generate new hypotheses and conclusions. Our results strongly suggest that the Rac/Cdc42 induced p38 and JNK cascades are independent of PI3K in both primary hepatocytes and HepG2. Furthermore, we detected that the activation of JNK in response to neuregulin follows a PI3K-dependent signaling pathway.},
	Author = {Samaga, Regina and Saez-Rodriguez, Julio and Alexopoulos, Leonidas G and Sorger, Peter K and Klamt, Steffen},
	Date-Added = {2016-01-06 23:09:31 +0000},
	Date-Modified = {2016-01-06 23:09:31 +0000},
	Doi = {10.1371/journal.pcbi.1000438},
	Journal = {PLoS Comput Biol},
	Journal-Full = {PLoS computational biology},
	Mesh = {Algorithms; Cell Line, Tumor; Computational Biology; Computer Simulation; Databases, Factual; Feedback, Physiological; Hepatocytes; Humans; Liver Neoplasms; Models, Biological; Protein Interaction Mapping; Receptor, Epidermal Growth Factor; Signal Transduction},
	Month = {Aug},
	Number = {8},
	Pages = {e1000438},
	Pmc = {PMC2710522},
	Pmid = {19662154},
	Pst = {ppublish},
	Title = {The logic of EGFR/ErbB signaling: theoretical properties and analysis of high-throughput data},
	Volume = {5},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pcbi.1000438}}

@article{Salomon1995,
	Author = {Salomon, D S and Brandt, R and Ciardiello, F and Normanno, N},
	Date-Added = {2016-01-06 23:09:21 +0000},
	Date-Modified = {2016-01-06 23:09:21 +0000},
	Journal = {Crit Rev Oncol Hematol},
	Journal-Full = {Critical reviews in oncology/hematology},
	Mesh = {Animals; Brain Neoplasms; Breast Neoplasms; Cell Division; Cell Transformation, Neoplastic; Digestive System Neoplasms; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Growth Substances; Head and Neck Neoplasms; Humans; Lung Neoplasms; Melanoma; Neoplasm Proteins; Neoplasms; Neoplasms, Experimental; Oncogenes; Rats; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Signal Transduction; Urogenital Neoplasms},
	Month = {Jul},
	Number = {3},
	Pages = {183-232},
	Pmid = {7612182},
	Pst = {ppublish},
	Title = {Epidermal growth factor-related peptides and their receptors in human malignancies},
	Volume = {19},
	Year = {1995}}

@article{Sahin2009,
	Abstract = {BACKGROUND: In breast cancer, overexpression of the transmembrane tyrosine kinase ERBB2 is an adverse prognostic marker, and occurs in almost 30% of the patients. For therapeutic intervention, ERBB2 is targeted by monoclonal antibody trastuzumab in adjuvant settings; however, de novo resistance to this antibody is still a serious issue, requiring the identification of additional targets to overcome resistance. In this study, we have combined computational simulations, experimental testing of simulation results, and finally reverse engineering of a protein interaction network to define potential therapeutic strategies for de novo trastuzumab resistant breast cancer.
RESULTS: First, we employed Boolean logic to model regulatory interactions and simulated single and multiple protein loss-of-functions. Then, our simulation results were tested experimentally by producing single and double knockdowns of the network components and measuring their effects on G1/S transition during cell cycle progression. Combinatorial targeting of ERBB2 and EGFR did not affect the response to trastuzumab in de novo resistant cells, which might be due to decoupling of receptor activation and cell cycle progression. Furthermore, examination of c-MYC in resistant as well as in sensitive cell lines, using a specific chemical inhibitor of c-MYC (alone or in combination with trastuzumab), demonstrated that both trastuzumab sensitive and resistant cells responded to c-MYC perturbation.
CONCLUSION: In this study, we connected ERBB signaling with G1/S transition of the cell cycle via two major cell signaling pathways and two key transcription factors, to model an interaction network that allows for the identification of novel targets in the treatment of trastuzumab resistant breast cancer. Applying this new strategy, we found that, in contrast to trastuzumab sensitive breast cancer cells, combinatorial targeting of ERBB receptors or of key signaling intermediates does not have potential for treatment of de novo trastuzumab resistant cells. Instead, c-MYC was identified as a novel potential target protein in breast cancer cells.},
	Author = {Sahin, Ozg{\"u}r and Fr{\"o}hlich, Holger and L{\"o}bke, Christian and Korf, Ulrike and Burmester, Sara and Majety, Meher and Mattern, Jens and Schupp, Ingo and Chaouiya, Claudine and Thieffry, Denis and Poustka, Annemarie and Wiemann, Stefan and Beissbarth, Tim and Arlt, Dorit},
	Date-Added = {2016-01-06 23:09:10 +0000},
	Date-Modified = {2016-01-06 23:09:10 +0000},
	Doi = {10.1186/1752-0509-3-1},
	Journal = {BMC Syst Biol},
	Journal-Full = {BMC systems biology},
	Mesh = {Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Computer Simulation; DNA-Binding Proteins; Drug Delivery Systems; Female; G1 Phase; Humans; Models, Biological; Protein Engineering; Receptor, Epidermal Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transcription Factors},
	Pages = {1},
	Pmc = {PMC2652436},
	Pmid = {19118495},
	Pst = {epublish},
	Title = {Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance},
	Volume = {3},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/1752-0509-3-1}}

@article{Saez-Rodriguez2011,
	Abstract = {Substantial effort in recent years has been devoted to constructing and analyzing large-scale gene and protein networks on the basis of "omic" data and literature mining. These interaction graphs provide valuable insight into the topologies of complex biological networks but are rarely context specific and cannot be used to predict the responses of cell signaling proteins to specific ligands or drugs. Conversely, traditional approaches to analyzing cell signaling are narrow in scope and cannot easily make use of network-level data. Here, we combine network analysis and functional experimentation by using a hybrid approach in which graphs are converted into simple mathematical models that can be trained against biochemical data. Specifically, we created Boolean logic models of immediate-early signaling in liver cells by training a literature-based prior knowledge network against biochemical data obtained from primary human hepatocytes and 4 hepatocellular carcinoma cell lines exposed to combinations of cytokines and small-molecule kinase inhibitors. Distinct families of models were recovered for each cell type, and these families clustered topologically into normal and diseased sets.},
	Author = {Saez-Rodriguez, Julio and Alexopoulos, Leonidas G and Zhang, Mingsheng and Morris, Melody K and Lauffenburger, Douglas A and Sorger, Peter K},
	Date-Added = {2016-01-06 23:09:01 +0000},
	Date-Modified = {2016-01-06 23:09:01 +0000},
	Doi = {10.1158/0008-5472.CAN-10-4453},
	Journal = {Cancer Res},
	Journal-Full = {Cancer research},
	Mesh = {Cell Line, Transformed; Cell Line, Tumor; Hepatocytes; Humans; Models, Biological; Signal Transduction},
	Month = {Aug},
	Number = {16},
	Pages = {5400-11},
	Pmc = {PMC3207250},
	Pmid = {21742771},
	Pst = {ppublish},
	Title = {Comparing signaling networks between normal and transformed hepatocytes using discrete logical models},
	Volume = {71},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1158/0008-5472.CAN-10-4453}}

@article{Saez-Rodriguez2009,
	Abstract = {Large-scale protein signalling networks are useful for exploring complex biochemical pathways but do not reveal how pathways respond to specific stimuli. Such specificity is critical for understanding disease and designing drugs. Here we describe a computational approach--implemented in the free CNO software--for turning signalling networks into logical models and calibrating the models against experimental data. When a literature-derived network of 82 proteins covering the immediate-early responses of human cells to seven cytokines was modelled, we found that training against experimental data dramatically increased predictive power, despite the crudeness of Boolean approximations, while significantly reducing the number of interactions. Thus, many interactions in literature-derived networks do not appear to be functional in the liver cells from which we collected our data. At the same time, CNO identified several new interactions that improved the match of model to data. Although missing from the starting network, these interactions have literature support. Our approach, therefore, represents a means to generate predictive, cell-type-specific models of mammalian signalling from generic protein signalling networks.},
	Author = {Saez-Rodriguez, Julio and Alexopoulos, Leonidas G and Epperlein, Jonathan and Samaga, Regina and Lauffenburger, Douglas A and Klamt, Steffen and Sorger, Peter K},
	Date-Added = {2016-01-06 23:08:59 +0000},
	Date-Modified = {2016-01-06 23:08:59 +0000},
	Doi = {10.1038/msb.2009.87},
	Journal = {Mol Syst Biol},
	Journal-Full = {Molecular systems biology},
	Mesh = {Computational Biology; Cytokines; Humans; Liver; Models, Biological; Proteins; Signal Transduction; Software},
	Pages = {331},
	Pmc = {PMC2824489},
	Pmid = {19953085},
	Pst = {ppublish},
	Title = {Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction},
	Volume = {5},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/msb.2009.87}}

@article{Saez-Rodriguez2007,
	Abstract = {Cellular decisions are determined by complex molecular interaction networks. Large-scale signaling networks are currently being reconstructed, but the kinetic parameters and quantitative data that would allow for dynamic modeling are still scarce. Therefore, computational studies based upon the structure of these networks are of great interest. Here, a methodology relying on a logical formalism is applied to the functional analysis of the complex signaling network governing the activation of T cells via the T cell receptor, the CD4/CD8 co-receptors, and the accessory signaling receptor CD28. Our large-scale Boolean model, which comprises 94 nodes and 123 interactions and is based upon well-established qualitative knowledge from primary T cells, reveals important structural features (e.g., feedback loops and network-wide dependencies) and recapitulates the global behavior of this network for an array of published data on T cell activation in wild-type and knock-out conditions. More importantly, the model predicted unexpected signaling events after antibody-mediated perturbation of CD28 and after genetic knockout of the kinase Fyn that were subsequently experimentally validated. Finally, we show that the logical model reveals key elements and potential failure modes in network functioning and provides candidates for missing links. In summary, our large-scale logical model for T cell activation proved to be a promising in silico tool, and it inspires immunologists to ask new questions. We think that it holds valuable potential in foreseeing the effects of drugs and network modifications.},
	Author = {Saez-Rodriguez, Julio and Simeoni, Luca and Lindquist, Jonathan A and Hemenway, Rebecca and Bommhardt, Ursula and Arndt, Boerge and Haus, Utz-Uwe and Weismantel, Robert and Gilles, Ernst D and Klamt, Steffen and Schraven, Burkhart},
	Date-Added = {2016-01-06 23:08:52 +0000},
	Date-Modified = {2016-01-06 23:08:52 +0000},
	Doi = {10.1371/journal.pcbi.0030163},
	Journal = {PLoS Comput Biol},
	Journal-Full = {PLoS computational biology},
	Mesh = {Computer Simulation; Logistic Models; Models, Immunological; Receptors, Antigen, T-Cell; Signal Transduction; T-Lymphocytes},
	Month = {Aug},
	Number = {8},
	Pages = {e163},
	Pmc = {PMC1950951},
	Pmid = {17722974},
	Pst = {ppublish},
	Title = {A logical model provides insights into T cell receptor signaling},
	Volume = {3},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pcbi.0030163}}

@article{Ryall2015,
	Abstract = {Complex diseases like cancer are regulated by large, interconnected networks with many pathways affecting cell proliferation, invasion, and drug resistance. However, current cancer therapy predominantly relies on the reductionist approach of one gene-one disease. Combinations of drugs may overcome drug resistance by limiting mutations and induction of escape pathways, but given the enormous number of possible drug combinations, strategies to reduce the search space and prioritize experiments are needed. In this review, we focus on the use of computational modeling, bioinformatics and high-throughput experimental methods for discovery of drug combinations. We highlight cutting-edge systems approaches, including large-scale modeling of cell signaling networks, network motif analysis, statistical association-based models, identifying correlations in gene signatures, functional genomics, and high-throughput combination screens. We also present a list of publicly available data and resources to aid in discovery of drug combinations. Integration of these systems approaches will enable faster discovery and translation of clinically relevant drug combinations. Graphical abstractSpectrum of Systems Biology Approaches for Drug Combinations.},
	Author = {Ryall, Karen A and Tan, Aik Choon},
	Date-Added = {2016-01-06 23:08:32 +0000},
	Date-Modified = {2016-01-06 23:08:32 +0000},
	Doi = {10.1186/s13321-015-0055-9},
	Journal = {J Cheminform},
	Journal-Full = {Journal of cheminformatics},
	Keywords = {Cancer; Computational modeling; Drug combinations; Drug discovery; Systems biology},
	Pages = {7},
	Pmc = {PMC4348553},
	Pmid = {25741385},
	Pst = {epublish},
	Title = {Systems biology approaches for advancing the discovery of effective drug combinations},
	Volume = {7},
	Year = {2015},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/s13321-015-0055-9}}

@article{Rehm2006,
	Abstract = {Activation of effector caspases is a final step during apoptosis. Single-cell imaging studies have demonstrated that this process may occur as a rapid, all-or-none response, triggering a complete substrate cleavage within 15 min. Based on biochemical data from HeLa cells, we have developed a computational model of apoptosome-dependent caspase activation that was sufficient to remodel the rapid kinetics of effector caspase activation observed in vivo. Sensitivity analyses predicted a critical role for caspase-3-dependent feedback signalling and the X-linked-inhibitor-of-apoptosis-protein (XIAP), but a less prominent role for the XIAP antagonist Smac. Single-cell experiments employing a caspase fluorescence resonance energy transfer substrate verified these model predictions qualitatively and quantitatively. XIAP was predicted to control this all-or-none response, with concentrations as high as 0.15 microM enabling, but concentrations >0.30 microM significantly blocking substrate cleavage. Overexpression of XIAP within these threshold concentrations produced cells showing slow effector caspase activation and submaximal substrate cleavage. Our study supports the hypothesis that high levels of XIAP control caspase activation and substrate cleavage, and may promote apoptosis resistance and sublethal caspase activation in vivo.},
	Author = {Rehm, Markus and Huber, Heinrich J and Dussmann, Heiko and Prehn, Jochen H M},
	Date-Added = {2016-01-06 23:07:29 +0000},
	Date-Modified = {2016-01-06 23:07:29 +0000},
	Doi = {10.1038/sj.emboj.7601295},
	Journal = {EMBO J},
	Journal-Full = {The EMBO journal},
	Mesh = {Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Cytosol; Enzyme Activation; Feedback; Gene Expression; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Mitochondrial Proteins; Models, Biological; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Signal Transduction; Systems Analysis; Transfection; X-Linked Inhibitor of Apoptosis Protein},
	Month = {Sep},
	Number = {18},
	Pages = {4338-49},
	Pmc = {PMC1570423},
	Pmid = {16932741},
	Pst = {ppublish},
	Title = {Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein},
	Volume = {25},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/sj.emboj.7601295}}

@article{Reddy1996,
	Abstract = {Successful use of growth factors in therapeutic and bioprocessing applications requires overcoming two attenuation mechanisms: growth factor depletion and receptor down-regulation. Current ameliorative strategies use physiologically inappropriate high growth-factor concentrations, along with periodic media refeeding in vitro and reinjection or controlled-release devices in vivo. We demonstrate a new approach derived from understanding how these attenuation mechanisms arise from ligand/receptor trafficking processes. Specifically, a recombinant epidermal growth factor (EGF) mutant with reduced receptor binding affinity is a more potent mitogenic stimulus for fibroblasts than natural EGF or transforming growth factor alpha because of its altered trafficking properties.},
	Author = {Reddy, C C and Niyogi, S K and Wells, A and Wiley, H S and Lauffenburger, D A},
	Date-Added = {2016-01-06 23:05:01 +0000},
	Date-Modified = {2016-01-06 23:05:01 +0000},
	Doi = {10.1038/nbt1296-1696},
	Journal = {Nat Biotechnol},
	Journal-Full = {Nature biotechnology},
	Mesh = {3T3 Cells; Animals; Cell Division; Down-Regulation; Epidermal Growth Factor; Fibroblasts; Gene Expression Regulation; Genetic Engineering; Mice; Mitogens; Mutation; Receptor, Epidermal Growth Factor; Recombinant Proteins; Signal Transduction; Transforming Growth Factor alpha},
	Month = {Dec},
	Number = {13},
	Pages = {1696-9},
	Pmid = {9634854},
	Pst = {ppublish},
	Title = {Engineering epidermal growth factor for enhanced mitogenic potency},
	Volume = {14},
	Year = {1996},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nbt1296-1696}}

@article{Qutub2009,
	Abstract = {Vascular disease, cancer, stroke, neurodegeneration, diabetes, inflammation, asthma, obesity, arthritis--the list of conditions that involve angiogenesis reads like main chapters in a book on pathology. Angiogenesis, the growth of capillaries from preexisting vessels, also occurs in normal physiology, in response to exercise or in the process of wound healing.Why and when is angiogenesis prevalent? What controls the process? How can we intelligently control it? These are the key questions driving researchers in fields as diverse as cell biology, oncology, cardiology, neurology, biomathematics, systems biology, and biomedical engineering. As bioengineers, we approach angiogenesis as a complex, interconnected system of events occurring in sequence and in parallel, on multiple levels, triggered by a main stimulus, e.g., hypoxia.},
	Author = {Qutub, Amina A and Mac Gabhann, Feilim and Karagiannis, Emmanouil D and Vempati, Prakash and Popel, Aleksander S},
	Date = {2009 Mar-Apr},
	Date-Added = {2016-01-06 23:04:51 +0000},
	Date-Modified = {2016-01-06 23:04:51 +0000},
	Doi = {10.1109/MEMB.2009.931791},
	Journal = {IEEE Eng Med Biol Mag},
	Journal-Full = {IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine \& Biology Society},
	Mesh = {Computational Biology; Computer Simulation; Humans; Hypoxia-Inducible Factor 1; Matrix Metalloproteinases; Models, Cardiovascular; Neovascularization, Physiologic; Vascular Endothelial Growth Factor A},
	Number = {2},
	Pages = {14-31},
	Pmc = {PMC3077679},
	Pmid = {19349248},
	Pst = {ppublish},
	Title = {Multiscale models of angiogenesis},
	Volume = {28},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1109/MEMB.2009.931791}}

@article{Pollack2011,
	Author = {A Pollack},
	Date-Added = {2016-01-06 23:04:23 +0000},
	Date-Modified = {2016-01-06 23:04:23 +0000},
	Journal = {The New York Times},
	Month = {November},
	Title = {F.D.A. revokes approval of Avastin for Use as Breast Cancer Drug},
	Url = {http://www.nytimes.com/2011/11/19/business/fda-revokes-approval-of-avastin-as-breast-cancer-drug.html},
	Urldate = {Nov 18, 2011},
	Year = {2011},
	Bdsk-Url-1 = {http://www.nytimes.com/2011/11/19/business/fda-revokes-approval-of-avastin-as-breast-cancer-drug.html}}

@article{Perfahl2011,
	Abstract = {We investigate a three-dimensional multiscale model of vascular tumour growth, which couples blood flow, angiogenesis, vascular remodelling, nutrient/growth factor transport, movement of, and interactions between, normal and tumour cells, and nutrient-dependent cell cycle dynamics within each cell. In particular, we determine how the domain size, aspect ratio and initial vascular network influence the tumour's growth dynamics and its long-time composition. We establish whether it is possible to extrapolate simulation results obtained for small domains to larger ones, by constructing a large simulation domain from a number of identical subdomains, each subsystem initially comprising two parallel parent vessels, with associated cells and diffusible substances. We find that the subsystem is not representative of the full domain and conclude that, for this initial vessel geometry, interactions between adjacent subsystems contribute to the overall growth dynamics. We then show that extrapolation of results from a small subdomain to a larger domain can only be made if the subdomain is sufficiently large and is initialised with a sufficiently complex vascular network. Motivated by these results, we perform simulations to investigate the tumour's response to therapy and show that the probability of tumour elimination in a larger domain can be extrapolated from simulation results on a smaller domain. Finally, we demonstrate how our model may be combined with experimental data, to predict the spatio-temporal evolution of a vascular tumour.},
	Author = {Perfahl, Holger and Byrne, Helen M and Chen, Tingan and Estrella, Veronica and Alarc{\'o}n, Tom{\'a}s and Lapin, Alexei and Gatenby, Robert A and Gillies, Robert J and Lloyd, Mark C and Maini, Philip K and Reuss, Matthias and Owen, Markus R},
	Date-Added = {2016-01-06 23:04:02 +0000},
	Date-Modified = {2016-01-06 23:04:02 +0000},
	Doi = {10.1371/journal.pone.0014790},
	Journal = {PLoS One},
	Journal-Full = {PloS one},
	Mesh = {Humans; Models, Anatomic; Neoplasms; Neovascularization, Pathologic; Stochastic Processes; Vascular Endothelial Growth Factor A},
	Number = {4},
	Pages = {e14790},
	Pmc = {PMC3076378},
	Pmid = {21533234},
	Pst = {epublish},
	Title = {Multiscale modelling of vascular tumour growth in 3D: the roles of domain size and boundary conditions},
	Volume = {6},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pone.0014790}}

@article{Morris2010,
	Abstract = {Computational models are increasingly used to analyze the operation of complex biochemical networks, including those involved in cell signaling networks. Here we review recent advances in applying logic-based modeling to mammalian cell biology. Logic-based models represent biomolecular networks in a simple and intuitive manner without describing the detailed biochemistry of each interaction. A brief description of several logic-based modeling methods is followed by six case studies that demonstrate biological questions recently addressed using logic-based models and point to potential advances in model formalisms and training procedures that promise to enhance the utility of logic-based methods for studying the relationship between environmental inputs and phenotypic or signaling state outputs of complex signaling networks.},
	Author = {Morris, Melody K and Saez-Rodriguez, Julio and Sorger, Peter K and Lauffenburger, Douglas A},
	Date-Added = {2016-01-06 23:01:55 +0000},
	Date-Modified = {2016-01-06 23:01:55 +0000},
	Doi = {10.1021/bi902202q},
	Journal = {Biochemistry},
	Journal-Full = {Biochemistry},
	Mesh = {Biochemistry; Cell Physiological Phenomena; Computers, Molecular; Fuzzy Logic; Kinetics; Logic; Models, Biological; Molecular Biology; Proteins; Signal Transduction},
	Month = {Apr},
	Number = {15},
	Pages = {3216-24},
	Pmc = {PMC2853906},
	Pmid = {20225868},
	Pst = {ppublish},
	Title = {Logic-based models for the analysis of cell signaling networks},
	Volume = {49},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1021/bi902202q}}

@article{Massey2012,
	Abstract = {Currently available glioma treatments remain unsuccessful at prolonging disease-free remission. Recent evidence suggests that tumour recruitment of glial progenitor cells by platelet-derived growth factor (PDGF) may play a role in the development and progression of these tumours. Building upon our recent experimental results and previous proliferation-invasion (PI) reaction-diffusion model, in this study, we created a proliferation-invasion-recruitment (PIR) model that includes a mechanism for progenitor cell recruitment, wherein paracrine PDGF signalling stimulates migration and proliferation of progenitors derived from the local brain environment. Parametrizing this mathematical model with data obtained from the PDGF-driven rat glioma model, we explored the consequences of recruitment, using the PIR model to compare the effects of high versus low PDGF secretion rates on tumour growth and invasion dynamics. The mathematical model predicts correlation between high levels of recruitment and both increased radial velocity of expansion on magnetic resonance imaging and less diffusely invasive edges. Thus, the PIR model predicts that PDGF levels correlate with tumour aggressiveness, and results are consistent with both human and experimental data, demonstrating that the effects of progenitor cell recruitment provide a novel mechanism to explain the variability in the rates of proliferation and dispersion observed in human gliomas.},
	Author = {Massey, Susan Christine and Assanah, Marcela C and Lopez, Kim A and Canoll, Peter and Swanson, Kristin R},
	Date-Added = {2016-01-06 23:01:19 +0000},
	Date-Modified = {2016-01-06 23:01:19 +0000},
	Doi = {10.1098/rsif.2012.0030},
	Journal = {J R Soc Interface},
	Journal-Full = {Journal of the Royal Society, Interface / the Royal Society},
	Mesh = {Animals; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Models, Biological; Neoplasm Invasiveness; Neuroglia; Rats; Stem Cells},
	Month = {Aug},
	Number = {73},
	Pages = {1757-66},
	Pmc = {PMC3385768},
	Pmid = {22319102},
	Pst = {ppublish},
	Title = {Glial progenitor cell recruitment drives aggressive glioma growth: mathematical and experimental modelling},
	Volume = {9},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1098/rsif.2012.0030}}

@article{Luan2010,
	Abstract = {The role of mechanistic modeling and systems biology in molecular medicine remains unclear. In this study, we explored whether uncertain models could be used to understand how a network responds to a therapeutic intervention. As a proof of concept, we modeled and analyzed the response of the human coagulation cascade to recombinant factor VIIa (rFVIIa) and prothrombin (fII) addition in normal and hemophilic plasma. An ensemble of parametrically uncertain human coagulation models was developed (N = 437). Each model described the time evolution of 193 proteins and protein complexes interconnected by 301 interactions under quiescent flow. The 467 unknown model parameters were estimated, using multiobjective optimization, from published in vitro coagulation studies. The model ensemble was validated using published in vitro thrombin measurements and thrombin measurements taken from coronary artery disease patients. Sensitivity analysis was then used to rank-order the importance of model parameters as a function of experimental or physiological conditions. A novel strategy for the systematic comparison of ranks identified a family of fX/FXa and fII/FIIa interactions that became more sensitive with decreasing fVIII/fIX. The fragility of these interactions was preserved following the addition of exogenous rFVIIa and fII. This suggested that exogenous rFVIIa did not alter the qualitative operation of the cascade. Rather, exogenous rFVIIa and fII took advantage of existing fluid and interfacial fX/FXa and fII/FIIa sensitivity to restore normal coagulation in low fVIII/fIX conditions. The proposed rFVIIa mechanism of action was consistent with experimental literature not used in model training. Thus, we demonstrated that an ensemble of uncertain models could unravel key facets of the mechanism of action of a focused intervention. Whereas the current study was limited to coagulation, perhaps the general strategy used could be extended to other molecular networks relevant to human health.},
	Author = {Luan, Deyan and Szlam, Fania and Tanaka, Kenichi A and Barie, Philip S and Varner, Jeffrey D},
	Date-Added = {2016-01-06 23:00:39 +0000},
	Date-Modified = {2016-01-06 23:00:39 +0000},
	Doi = {10.1039/b920693k},
	Journal = {Mol Biosyst},
	Journal-Full = {Molecular bioSystems},
	Mesh = {Blood Coagulation; Computer Simulation; Factor IX; Factor VIIa; Hemophilia A; Humans; Models, Biological; Recombinant Proteins; Reproducibility of Results; Thrombin; Time Factors; Uncertainty},
	Month = {Nov},
	Number = {11},
	Pages = {2272-86},
	Pmid = {20844798},
	Pst = {ppublish},
	Title = {Ensembles of uncertain mathematical models can identify network response to therapeutic interventions},
	Volume = {6},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1039/b920693k}}

@article{Lequieu2011,
	Abstract = {Insulin, the primary hormone regulating the level of glucose in the bloodstream, modulates a variety of cellular and enzymatic processes in normal and diseased cells. Insulin signals are processed by a complex network of biochemical interactions which ultimately induce gene expression programs or other processes such as translation initiation. Surprisingly, despite the wealth of literature on insulin signaling, the relative importance of the components linking insulin with translation initiation remains unclear. We addressed this question by developing and interrogating a family of mathematical models of insulin induced translation initiation. The insulin network was modeled using mass-action kinetics within an ordinary differential equation (ODE) framework. A family of model parameters was estimated, starting from an initial best fit parameter set, using 24 experimental data sets taken from literature. The residual between model simulations and each of the experimental constraints were simultaneously minimized using multiobjective optimization. Interrogation of the model population, using sensitivity and robustness analysis, identified an insulin-dependent switch that controlled translation initiation. Our analysis suggested that without insulin, a balance between the pro-initiation activity of the GTP-binding protein Rheb and anti-initiation activity of PTEN controlled basal initiation. On the other hand, in the presence of insulin a combination of PI3K and Rheb activity controlled inducible initiation, where PI3K was only critical in the presence of insulin. Other well known regulatory mechanisms governing insulin action, for example IRS-1 negative feedback, modulated the relative importance of PI3K and Rheb but did not fundamentally change the signal flow.},
	Author = {Lequieu, Joshua and Chakrabarti, Anirikh and Nayak, Satyaprakash and Varner, Jeffrey D},
	Date-Added = {2016-01-06 22:59:18 +0000},
	Date-Modified = {2016-01-06 22:59:18 +0000},
	Doi = {10.1371/journal.pcbi.1002263},
	Journal = {PLoS Comput Biol},
	Journal-Full = {PLoS computational biology},
	Mesh = {Animals; Computer Simulation; Eukaryota; Humans; Insulin; Insulin Receptor Substrate Proteins; PTEN Phosphohydrolase; Peptide Chain Initiation, Translational; Phosphatidylinositol 3-Kinases; Phosphorylation; Signal Transduction},
	Month = {Nov},
	Number = {11},
	Pages = {e1002263},
	Pmc = {PMC3213178},
	Pmid = {22102801},
	Pst = {ppublish},
	Title = {Computational modeling and analysis of insulin induced eukaryotic translation initiation},
	Volume = {7},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pcbi.1002263}}

@article{Leeuwen2007,
	Abstract = {Wnt signalling is involved in a wide range of physiological and pathological processes. The presence of an extracellular Wnt stimulus induces cytoplasmic stabilisation and nuclear translocation of beta-catenin, a protein that also plays an essential role in cadherin-mediated adhesion. Two main hypotheses have been proposed concerning the balance between beta-catenin's adhesive and transcriptional functions: either beta-catenin's fate is determined by competition between its binding partners, or Wnt induces folding of beta-catenin into a conformation allocated preferentially to transcription. The experimental data supporting each hypotheses remain inconclusive. In this paper we present a new mathematical model of the Wnt pathway that incorporates beta-catenin's dual function. We use this model to carry out a series of in silico experiments and compare the behaviour of systems governed by each hypothesis. Our analytical results and model simulations provide further insight into the current understanding of Wnt signalling and, in particular, reveal differences in the response of the two modes of interaction between adhesion and signalling in certain in silico settings. We also exploit our model to investigate the impact of the mutations most commonly observed in human colorectal cancer. Simulations show that the amount of functional APC required to maintain a normal phenotype increases with increasing strength of the Wnt signal, a result which illustrates that the environment can substantially influence both tumour initiation and phenotype.},
	Author = {van Leeuwen, Ingeborg M M and Byrne, Helen M and Jensen, Oliver E and King, John R},
	Date-Added = {2016-01-06 22:59:09 +0000},
	Date-Modified = {2016-01-06 22:59:09 +0000},
	Doi = {10.1016/j.jtbi.2007.01.019},
	Journal = {J Theor Biol},
	Journal-Full = {Journal of theoretical biology},
	Mesh = {Cadherins; Cell Adhesion; Cell Transformation, Neoplastic; Colorectal Neoplasms; Genes, APC; Humans; Models, Biological; Mutation; Neoplasm Proteins; Signal Transduction; Transcription, Genetic; Wnt Proteins; beta Catenin},
	Month = {Jul},
	Number = {1},
	Pages = {77-102},
	Pmid = {17382967},
	Pst = {ppublish},
	Title = {Elucidating the interactions between the adhesive and transcriptional functions of beta-catenin in normal and cancerous cells},
	Volume = {247},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.jtbi.2007.01.019}}

@article{Leeuwen2009,
	Abstract = {OBJECTIVES: The luminal surface of the gut is lined with a monolayer of epithelial cells that acts as a nutrient absorptive engine and protective barrier. To maintain its integrity and functionality, the epithelium is renewed every few days. Theoretical models are powerful tools that can be used to test hypotheses concerning the regulation of this renewal process, to investigate how its dysfunction can lead to loss of homeostasis and neoplasia, and to identify potential therapeutic interventions. Here we propose a new multiscale model for crypt dynamics that links phenomena occurring at the subcellular, cellular and tissue levels of organisation.
METHODS: At the subcellular level, deterministic models characterise molecular networks, such as cell-cycle control and Wnt signalling. The output of these models determines the behaviour of each epithelial cell in response to intra-, inter- and extracellular cues. The modular nature of the model enables us to easily modify individual assumptions and analyse their effects on the system as a whole.
RESULTS: We perform virtual microdissection and labelling-index experiments, evaluate the impact of various model extensions, obtain new insight into clonal expansion in the crypt, and compare our predictions with recent mitochondrial DNA mutation data.
CONCLUSIONS: We demonstrate that relaxing the assumption that stem-cell positions are fixed enables clonal expansion and niche succession to occur. We also predict that the presence of extracellular factors near the base of the crypt alone suffices to explain the observed spatial variation in nuclear beta-catenin levels along the crypt axis.},
	Author = {van Leeuwen, I M M and Mirams, G R and Walter, A and Fletcher, A and Murray, P and Osborne, J and Varma, S and Young, S J and Cooper, J and Doyle, B and Pitt-Francis, J and Momtahan, L and Pathmanathan, P and Whiteley, J P and Chapman, S J and Gavaghan, D J and Jensen, O E and King, J R and Maini, P K and Waters, S L and Byrne, H M},
	Date-Added = {2016-01-06 22:59:09 +0000},
	Date-Modified = {2016-01-06 22:59:09 +0000},
	Doi = {10.1111/j.1365-2184.2009.00627.x},
	Journal = {Cell Prolif},
	Journal-Full = {Cell proliferation},
	Mesh = {Animals; Cell Adhesion; Colon; Computer Simulation; Extracellular Matrix; Humans; Intestinal Mucosa; Mitosis; Models, Biological; Mucous Membrane; Regeneration; Signal Transduction; Stem Cells; Wnt Proteins; beta Catenin},
	Month = {Oct},
	Number = {5},
	Pages = {617-36},
	Pmid = {19622103},
	Pst = {ppublish},
	Title = {An integrative computational model for intestinal tissue renewal},
	Volume = {42},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1111/j.1365-2184.2009.00627.x}}

@article{Lee2012,
	Abstract = {Crosstalk and complexity within signaling pathways and their perturbation by oncogenes limit component-by-component approaches to understanding human disease. Network analysis of how normal and oncogenic signaling can be rewired by drugs may provide opportunities to target tumors with high specificity and efficacy. Using targeted inhibition of oncogenic signaling pathways, combined with DNA-damaging chemotherapy, we report that time-staggered EGFR inhibition, but not simultaneous coadministration, dramatically sensitizes a subset of triple-negative breast cancer cells to genotoxic drugs. Systems-level analysis-using high-density time-dependent measurements of signaling networks, gene expression profiles, and cell phenotypic responses in combination with mathematical modeling-revealed an approach for altering the intrinsic state of the cell through dynamic rewiring of oncogenic signaling pathways. This process converts these cells to a less tumorigenic state that is more susceptible to DNA damage-induced cell death by reactivation of an extrinsic apoptotic pathway whose function is suppressed in the oncogene-addicted state.},
	Author = {Lee, Michael J and Ye, Albert S and Gardino, Alexandra K and Heijink, Anne Margriet and Sorger, Peter K and MacBeath, Gavin and Yaffe, Michael B},
	Date-Added = {2016-01-06 22:58:57 +0000},
	Date-Modified = {2016-01-06 22:58:57 +0000},
	Doi = {10.1016/j.cell.2012.03.031},
	Journal = {Cell},
	Journal-Full = {Cell},
	Mesh = {Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 8; Cell Line, Tumor; DNA Damage; Drug Therapy, Combination; Female; Humans; Metabolic Networks and Pathways; Models, Biological; Receptor, Epidermal Growth Factor; Signal Transduction},
	Month = {May},
	Number = {4},
	Pages = {780-94},
	Pmc = {PMC3501264},
	Pmid = {22579283},
	Pst = {ppublish},
	Title = {Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks},
	Volume = {149},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.cell.2012.03.031}}

@article{Lazebnik2010,
	Abstract = {The seminal article by Douglas Hanahan and Robert Weinberg on the hallmarks of cancer is 10 years old this year and its contribution to how we see cancer has been substantial. But, in embracing this view, have we lost sight of what makes cancer cancer?},
	Author = {Lazebnik, Yuri},
	Date-Added = {2016-01-06 22:58:35 +0000},
	Date-Modified = {2016-01-06 22:58:35 +0000},
	Journal = {Nat Rev Cancer},
	Journal-Full = {Nature reviews. Cancer},
	Mesh = {Cell Cycle; Female; Humans; Male; Neoplasm Invasiveness; Neoplasms; Retinal Neoplasms; Retinoblastoma},
	Month = {Apr},
	Number = {4},
	Pages = {232-3},
	Pmid = {20355252},
	Pst = {ppublish},
	Title = {What are the hallmarks of cancer?},
	Volume = {10},
	Year = {2010}}

@article{Klinger2013,
	Abstract = {The epidermal growth factor receptor (EGFR) signaling network is activated in most solid tumors, and small-molecule drugs targeting this network are increasingly available. However, often only specific combinations of inhibitors are effective. Therefore, the prediction of potent combinatorial treatments is a major challenge in targeted cancer therapy. In this study, we demonstrate how a model-based evaluation of signaling data can assist in finding the most suitable treatment combination. We generated a perturbation data set by monitoring the response of RAS/PI3K signaling to combined stimulations and inhibitions in a panel of colorectal cancer cell lines, which we analyzed using mathematical models. We detected that a negative feedback involving EGFR mediates strong cross talk from ERK to AKT. Consequently, when inhibiting MAPK, AKT activity is increased in an EGFR-dependent manner. Using the model, we predict that in contrast to single inhibition, combined inactivation of MEK and EGFR could inactivate both endpoints of RAS, ERK and AKT. We further could demonstrate that this combination blocked cell growth in BRAF- as well as KRAS-mutated tumor cells, which we confirmed using a xenograft model.},
	Author = {Klinger, Bertram and Sieber, Anja and Fritsche-Guenther, Raphaela and Witzel, Franziska and Berry, Leanne and Schumacher, Dirk and Yan, Yibing and Durek, Pawel and Merchant, Mark and Sch{\"a}fer, Reinhold and Sers, Christine and Bl{\"u}thgen, Nils},
	Date-Added = {2016-01-06 22:57:26 +0000},
	Date-Modified = {2016-01-06 22:57:26 +0000},
	Doi = {10.1038/msb.2013.29},
	Journal = {Mol Syst Biol},
	Journal-Full = {Molecular systems biology},
	Mesh = {Animals; Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Models, Genetic; Phosphatidylinositol 3-Kinases; Protein Interaction Maps; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Receptor, Epidermal Growth Factor; Signal Transduction; Transplantation, Heterologous; Tumor Burden; ras Proteins},
	Pages = {673},
	Pmid = {23752269},
	Pst = {ppublish},
	Title = {Network quantification of EGFR signaling unveils potential for targeted combination therapy},
	Volume = {9},
	Year = {2013},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/msb.2013.29}}

@article{Kirouac2013,
	Abstract = {Crosstalk and compensatory circuits within cancer signaling networks limit the activity of most targeted therapies. For example, altered signaling in the networks activated by the ErbB family of receptors, particularly in ERBB2-amplified cancers, contributes to drug resistance. We developed a multiscale systems model of signaling networks in ERBB2-amplified breast cancer to quantitatively investigate relationships between biomarkers (markers of network activity) and combination drug efficacy. This model linked ErbB receptor family signaling to breast tumor growth through two kinase cascades: the PI3K/AKT survival pathway and the Ras/MEK/ERK growth and proliferation pathway. The model predicted molecular mechanisms of resistance to individual therapeutics. In particular, ERBB2-amplified breast cancer cells stimulated with the ErbB3 ligand heregulin were resistant to growth arrest induced by inhibitors of AKT and MEK or coapplication of two inhibitors of the receptor ErbB2 [Herceptin (trastuzumab) and Tykerb (lapatinib)]. We used model simulations to predict the response of ErbB2-positive breast cancer xenografts to combination therapies and verified these predictions in mice. Treatment with trastuzumab, lapatinib, and the ErbB3 inhibitor MM-111 was more effective in inhibiting tumor growth than the combination of AKT and MEK inhibitors and even induced tumor regression, indicating that targeting both ErbB3 and ErbB2 may be an improved therapeutic approach for ErbB2-positive breast cancer patients.},
	Author = {Kirouac, Daniel C and Du, Jin Y and Lahdenranta, Johanna and Overland, Ryan and Yarar, Defne and Paragas, Violette and Pace, Emily and McDonagh, Charlotte F and Nielsen, Ulrik B and Onsum, Matthew D},
	Date-Added = {2016-01-06 22:57:19 +0000},
	Date-Modified = {2016-01-06 22:57:19 +0000},
	Doi = {10.1126/scisignal.2004008},
	Journal = {Sci Signal},
	Journal-Full = {Science signaling},
	Month = {Aug},
	Number = {288},
	Pages = {ra68},
	Pmid = {23943608},
	Pst = {epublish},
	Title = {Computational modeling of ERBB2-amplified breast cancer identifies combined ErbB2/3 blockade as superior to the combination of MEK and AKT inhibitors},
	Volume = {6},
	Year = {2013},
	Bdsk-Url-1 = {http://dx.doi.org/10.1126/scisignal.2004008}}

@article{Kim2007,
	Abstract = {The Wnt and the extracellular signal regulated-kinase (ERK) pathways are both involved in the pathogenesis of various kinds of cancers. Recently, the existence of crosstalk between Wnt and ERK pathways was reported. Gathering all reported results, we have discovered a positive feedback loop embedded in the crosstalk between the Wnt and ERK pathways. We have developed a plausible model that represents the role of this hidden positive feedback loop in the Wnt/ERK pathway crosstalk based on the integration of experimental reports and employing established basic mathematical models of each pathway. Our analysis shows that the positive feedback loop can generate bistability in both the Wnt and ERK signaling pathways, and this prediction was further validated by experiments. In particular, using the commonly accepted assumption that mutations in signaling proteins contribute to cancerogenesis, we have found two conditions through which mutations could evoke an irreversible response leading to a sustained activation of both pathways. One condition is enhanced production of beta-catenin, the other is a reduction of the velocity of MAP kinase phosphatase(s). This enables that high activities of Wnt and ERK pathways are maintained even without a persistent extracellular signal. Thus, our study adds a novel aspect to the molecular mechanisms of carcinogenesis by showing that mutational changes in individual proteins can cause fundamental functional changes well beyond the pathway they function in by a positive feedback loop embedded in crosstalk. Thus, crosstalk between signaling pathways provides a vehicle through which mutations of individual components can affect properties of the system at a larger scale.},
	Author = {Kim, D and Rath, O and Kolch, W and Cho, K-H},
	Date-Added = {2016-01-06 22:57:09 +0000},
	Date-Modified = {2016-01-06 22:57:09 +0000},
	Doi = {10.1038/sj.onc.1210230},
	Journal = {Oncogene},
	Journal-Full = {Oncogene},
	Mesh = {Cell Line, Tumor; Cell Transformation, Neoplastic; Colorectal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Feedback; Humans; MAP Kinase Signaling System; Mathematics; Models, Biological; Mutation; Signal Transduction; TCF Transcription Factors; Wnt Proteins; beta Catenin},
	Month = {Jul},
	Number = {31},
	Pages = {4571-9},
	Pmid = {17237813},
	Pst = {ppublish},
	Title = {A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways},
	Volume = {26},
	Year = {2007},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/sj.onc.1210230}}

@article{Kholodenko1999,
	Abstract = {During the past decade, our knowledge of molecular mechanisms involved in growth factor signaling has proliferated almost explosively. However, the kinetics and control of information transfer through signaling networks remain poorly understood. This paper combines experimental kinetic analysis and computational modeling of the short term pattern of cellular responses to epidermal growth factor (EGF) in isolated hepatocytes. The experimental data show transient tyrosine phosphorylation of the EGF receptor (EGFR) and transient or sustained response patterns in multiple signaling proteins targeted by EGFR. Transient responses exhibit pronounced maxima, reached within 15-30 s of EGF stimulation and followed by a decline to relatively low (quasi-steady-state) levels. In contrast to earlier suggestions, we demonstrate that the experimentally observed transients can be accounted for without requiring receptor-mediated activation of specific tyrosine phosphatases, following EGF stimulation. The kinetic model predicts how the cellular response is controlled by the relative levels and activity states of signaling proteins and under what conditions activation patterns are transient or sustained. EGFR signaling patterns appear to be robust with respect to variations in many elemental rate constants within the range of experimentally measured values. On the other hand, we specify which changes in the kinetic scheme, rate constants, and total amounts of molecular factors involved are incompatible with the experimentally observed kinetics of signal transfer. Quantitation of signaling network responses to growth factors allows us to assess how cells process information controlling their growth and differentiation.},
	Author = {Kholodenko, B N and Demin, O V and Moehren, G and Hoek, J B},
	Date-Added = {2016-01-06 22:56:59 +0000},
	Date-Modified = {2016-01-06 22:56:59 +0000},
	Journal = {J Biol Chem},
	Journal-Full = {The Journal of biological chemistry},
	Mesh = {Animals; Isoenzymes; Kinetics; Liver; Male; Phospholipase C gamma; Rats; Rats, Sprague-Dawley; Receptor, Epidermal Growth Factor; Signal Transduction; Type C Phospholipases},
	Month = {Oct},
	Number = {42},
	Pages = {30169-81},
	Pmid = {10514507},
	Pst = {ppublish},
	Title = {Quantification of short term signaling by the epidermal growth factor receptor},
	Volume = {274},
	Year = {1999}}

@article{Kholodenko2012,
	Abstract = {The advancements in "omics" (proteomics, genomics, lipidomics, and metabolomics) technologies have yielded large inventories of genes, transcripts, proteins, and metabolites. The challenge is to find out how these entities work together to regulate the processes by which cells respond to external and internal signals. Mathematical and computational modeling of signaling networks has a key role in this task, and network analysis provides insights into biological systems and has applications for medicine. Here, we review experimental and theoretical progress and future challenges toward this goal. We focus on how networks are reconstructed from data, how these networks are structured to control the flow of biological information, and how the design features of the networks specify biological decisions.},
	Author = {Kholodenko, Boris and Yaffe, Michael B and Kolch, Walter},
	Date-Added = {2016-01-06 22:56:59 +0000},
	Date-Modified = {2016-01-06 22:56:59 +0000},
	Doi = {10.1126/scisignal.2002961},
	Journal = {Sci Signal},
	Journal-Full = {Science signaling},
	Mesh = {Computational Biology; Computer Simulation; Proteomics; Signal Transduction; Systems Biology},
	Month = {Apr},
	Number = {220},
	Pages = {re1},
	Pmid = {22510471},
	Pst = {epublish},
	Title = {Computational approaches for analyzing information flow in biological networks},
	Volume = {5},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1126/scisignal.2002961}}

@article{Kaul2013,
	Abstract = {Capturing the dynamism that pervades biological systems requires a computational approach that can accommodate both the continuous features of the system environment as well as the flexible and heterogeneous nature of component interactions. This presents a serious challenge for the more traditional mathematical approaches that assume component homogeneity to relate system observables using mathematical equations. While the homogeneity condition does not lead to loss of accuracy while simulating various continua, it fails to offer detailed solutions when applied to systems with dynamically interacting heterogeneous components. As the functionality and architecture of most biological systems is a product of multi-faceted individual interactions at the sub-system level, continuum models rarely offer much beyond qualitative similarity. Agent-based modelling is a class of algorithmic computational approaches that rely on interactions between Turing-complete finite-state machines-or agents-to simulate, from the bottom-up, macroscopic properties of a system. In recognizing the heterogeneity condition, they offer suitable ontologies to the system components being modelled, thereby succeeding where their continuum counterparts tend to struggle. Furthermore, being inherently hierarchical, they are quite amenable to coupling with other computational paradigms. The integration of any agent-based framework with continuum models is arguably the most elegant and precise way of representing biological systems. Although in its nascence, agent-based modelling has been utilized to model biological complexity across a broad range of biological scales (from cells to societies). In this article, we explore the reasons that make agent-based modelling the most precise approach to model biological systems that tend to be non-linear and complex.},
	Author = {Kaul, Himanshu and Ventikos, Yiannis},
	Date-Added = {2016-01-06 22:56:35 +0000},
	Date-Modified = {2016-01-06 22:56:35 +0000},
	Doi = {10.1093/bib/bbt077},
	Journal = {Brief Bioinform},
	Journal-Full = {Briefings in bioinformatics},
	Keywords = {agent-based model; biological complexity; cell; computational modeling; emergence; hybrid models},
	Month = {Nov},
	Pmid = {24227161},
	Pst = {aheadofprint},
	Title = {Investigating biocomplexity through the agent-based paradigm},
	Year = {2013},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/bib/bbt077}}

@article{Kalita2011,
	Abstract = {The canonical nuclear factor-B (NF-B) signaling pathway controls a gene network important in the cellular inflammatory response. Upon activation, NF-B/RelA is released from cytoplasmic inhibitors, from where it translocates into the nucleus, subsequently activating negative feedback loops producing either monophasic or damped oscillatory nucleo-cytoplasmic dynamics. Although the population behavior of the NF-B pathway has been extensively modeled, the sources of cell-to-cell variability are not well understood. We describe an integrated experimental-computational analysis of NF-B/RelA translocation in a validated cell model exhibiting monophasic dynamics. Quantitative measures of cellular geometry and total cytoplasmic concentration and translocated RelA amounts were used as priors in Bayesian inference to estimate biophysically realistic parameter values based on dynamic live cell imaging studies of enhanced GFP-tagged RelA in stable transfectants. Bayesian inference was performed on multiple cells simultaneously, assuming identical reaction rate parameters, whereas cellular geometry and initial and total NF-B concentration-related parameters were cell-specific. A subpopulation of cells exhibiting distinct kinetic profiles was identified that corresponded to differences in the IB translation rate. We conclude that cellular geometry, initial and total NF-B concentration, IB translation, and IB degradation rates account for distinct cell-to-cell differences in canonical NF-B translocation dynamics.},
	Author = {Kalita, Mridul K and Sargsyan, Khachik and Tian, Bing and Paulucci-Holthauzen, Adriana and Najm, Habib N and Debusschere, Bert J and Brasier, Allan R},
	Date-Added = {2016-01-06 22:54:52 +0000},
	Date-Modified = {2016-01-06 22:54:52 +0000},
	Doi = {10.1074/jbc.M111.280925},
	Journal = {J Biol Chem},
	Journal-Full = {The Journal of biological chemistry},
	Mesh = {Active Transport, Cell Nucleus; Cell Line; Cell Nucleus; Cytoplasm; Humans; I-kappa B Kinase; Kinetics; Models, Biological; Proteolysis; Signal Transduction; Transcription Factor RelA},
	Month = {Oct},
	Number = {43},
	Pages = {37741-57},
	Pmc = {PMC3199517},
	Pmid = {21868381},
	Pst = {ppublish},
	Title = {Sources of cell-to-cell variability in canonical nuclear factor-kappaB (NF-kappaB) signaling pathway inferred from single cell dynamic images},
	Volume = {286},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1074/jbc.M111.280925}}

@article{Jiang2005,
	Abstract = {The desire to understand tumor complexity has given rise to mathematical models to describe the tumor microenvironment. We present a new mathematical model for avascular tumor growth and development that spans three distinct scales. At the cellular level, a lattice Monte Carlo model describes cellular dynamics (proliferation, adhesion, and viability). At the subcellular level, a Boolean network regulates the expression of proteins that control the cell cycle. At the extracellular level, reaction-diffusion equations describe the chemical dynamics (nutrient, waste, growth promoter, and inhibitor concentrations). Data from experiments with multicellular spheroids were used to determine the parameters of the simulations. Starting with a single tumor cell, this model produces an avascular tumor that quantitatively mimics experimental measurements in multicellular spheroids. Based on the simulations, we predict: 1), the microenvironmental conditions required for tumor cell survival; and 2), growth promoters and inhibitors have diffusion coefficients in the range between 10(-6) and 10(-7) cm2/h, corresponding to molecules of size 80-90 kDa. Using the same parameters, the model also accurately predicts spheroid growth curves under different external nutrient supply conditions.},
	Author = {Jiang, Yi and Pjesivac-Grbovic, Jelena and Cantrell, Charles and Freyer, James P},
	Date-Added = {2016-01-06 22:54:05 +0000},
	Date-Modified = {2016-01-06 22:54:05 +0000},
	Doi = {10.1529/biophysj.105.060640},
	Journal = {Biophys J},
	Journal-Full = {Biophysical journal},
	Mesh = {Animals; Cell Adhesion; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Computer Simulation; Humans; Mammary Neoplasms, Experimental; Mice; Models, Biological; Neovascularization, Pathologic; Spheroids, Cellular},
	Month = {Dec},
	Number = {6},
	Pages = {3884-94},
	Pmc = {PMC1366955},
	Pmid = {16199495},
	Pst = {ppublish},
	Title = {A multiscale model for avascular tumor growth},
	Volume = {89},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1529/biophysj.105.060640}}

@article{Hynes2005,
	Abstract = {ERBB receptor tyrosine kinases have important roles in human cancer. In particular, the expression or activation of epidermal growth factor receptor and ERBB2 are altered in many epithelial tumours, and clinical studies indicate that they have important roles in tumour aetiology and progression. Accordingly, these receptors have been intensely studied to understand their importance in cancer biology and as therapeutic targets, and many ERBB inhibitors are now used in the clinic. We will discuss the significance of these receptors as clinical targets, in particular the molecular mechanisms underlying response.},
	Author = {Hynes, Nancy E and Lane, Heidi A},
	Date-Added = {2016-01-06 22:53:16 +0000},
	Date-Modified = {2016-01-06 22:53:16 +0000},
	Doi = {10.1038/nrc1609},
	Journal = {Nat Rev Cancer},
	Journal-Full = {Nature reviews. Cancer},
	Mesh = {Animals; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Neoplasms; Receptor Protein-Tyrosine Kinases; Receptor, erbB-2; Signal Transduction},
	Month = {May},
	Number = {5},
	Pages = {341-54},
	Pmid = {15864276},
	Pst = {ppublish},
	Title = {ERBB receptors and cancer: the complexity of targeted inhibitors},
	Volume = {5},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nrc1609}}

@article{Hutchinson2011,
	Author = {Hutchinson, Lisa and Kirk, Rebecca},
	Date-Added = {2016-01-06 22:52:21 +0000},
	Date-Modified = {2016-01-06 22:52:21 +0000},
	Doi = {10.1038/nrclinonc.2011.34},
	Journal = {Nat Rev Clin Oncol},
	Journal-Full = {Nature reviews. Clinical oncology},
	Mesh = {Animals; Drug Design; Drug Evaluation, Preclinical; Drug Industry; Drug-Related Side Effects and Adverse Reactions; Humans; Neoplasms},
	Month = {Apr},
	Number = {4},
	Pages = {189-90},
	Pmid = {21448176},
	Pst = {epublish},
	Title = {High drug attrition rates--where are we going wrong?},
	Volume = {8},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nrclinonc.2011.34}}

@article{Huang2000,
	Abstract = {Development of characteristic tissue patterns requires that individual cells be switched locally between different phenotypes or "fates;" while one cell may proliferate, its neighbors may differentiate or die. Recent studies have revealed that local switching between these different gene programs is controlled through interplay between soluble growth factors, insoluble extracellular matrix molecules, and mechanical forces which produce cell shape distortion. Although the precise molecular basis remains unknown, shape-dependent control of cell growth and function appears to be mediated by tension-dependent changes in the actin cytoskeleton. However, the question remains: how can a generalized physical stimulus, such as cell distortion, activate the same set of genes and signaling proteins that are triggered by molecules which bind to specific cell surface receptors. In this article, we use computer simulations based on dynamic Boolean networks to show that the different cell fates that a particular cell can exhibit may represent a preprogrammed set of common end programs or "attractors" which self-organize within the cell's regulatory networks. In this type of dynamic network model of information processing, generalized stimuli (e.g., mechanical forces) and specific molecular cues elicit signals which follow different trajectories, but eventually converge onto one of a small set of common end programs (growth, quiescence, differentiation, apoptosis, etc.). In other words, if cells use this type of information processing system, then control of cell function would involve selection of preexisting (latent) behavioral modes of the cell, rather than instruction by specific binding molecules. Importantly, the results of the computer simulation closely mimic experimental data obtained with living endothelial cells. The major implication of this finding is that current methods used for analysis of cell function that rely on characterization of linear signaling pathways or clusters of genes with common activity profiles may overlook the most critical features of cellular information processing which normally determine how signal specificity is established and maintained in living cells.},
	Author = {Huang, S and Ingber, D E},
	Date-Added = {2016-01-06 22:51:53 +0000},
	Date-Modified = {2016-01-06 22:51:53 +0000},
	Doi = {10.1006/excr.2000.5044},
	Journal = {Exp Cell Res},
	Journal-Full = {Experimental cell research},
	Keywords = {NASA Discipline Cell Biology; Non-NASA Center},
	Mesh = {Animals; Apoptosis; Cell Differentiation; Cell Division; Cell Physiological Phenomena; Cell Size; Homeostasis; Humans; Models, Biological},
	Month = {Nov},
	Number = {1},
	Pages = {91-103},
	Pmid = {11082279},
	Pst = {ppublish},
	Title = {Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks},
	Volume = {261},
	Year = {2000},
	Bdsk-Url-1 = {http://dx.doi.org/10.1006/excr.2000.5044}}

@article{Hoffmann2002,
	Abstract = {Nuclear localization of the transcriptional activator NF-kappaB (nuclear factor kappaB) is controlled in mammalian cells by three isoforms of NF-kappaB inhibitor protein: IkappaBalpha, -beta, and - epsilon. Based on simplifying reductions of the IkappaB-NF-kappaB signaling module in knockout cell lines, we present a computational model that describes the temporal control of NF-kappaB activation by the coordinated degradation and synthesis of IkappaB proteins. The model demonstrates that IkappaBalpha is responsible for strong negative feedback that allows for a fast turn-off of the NF-kappaB response, whereas IkappaBbeta and - epsilon function to reduce the system's oscillatory potential and stabilize NF-kappaB responses during longer stimulations. Bimodal signal-processing characteristics with respect to stimulus duration are revealed by the model and are shown to generate specificity in gene expression.},
	Author = {Hoffmann, Alexander and Levchenko, Andre and Scott, Martin L and Baltimore, David},
	Date-Added = {2016-01-06 22:51:30 +0000},
	Date-Modified = {2016-01-06 22:51:30 +0000},
	Doi = {10.1126/science.1071914},
	Journal = {Science},
	Journal-Full = {Science (New York, N.Y.)},
	Mesh = {Animals; Cell Line; Cell Nucleus; Chemokine CCL5; Chemokine CXCL10; Chemokines, CXC; Computer Simulation; Cytoplasm; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Feedback, Physiological; Gene Expression Regulation; Humans; I-kappa B Proteins; Mice; Mice, Knockout; Models, Biological; NF-kappa B; Proto-Oncogene Proteins; Signal Transduction; Transcriptional Activation; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha},
	Month = {Nov},
	Number = {5596},
	Pages = {1241-5},
	Pmid = {12424381},
	Pst = {ppublish},
	Title = {The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation},
	Volume = {298},
	Year = {2002},
	Bdsk-Url-1 = {http://dx.doi.org/10.1126/science.1071914}}

@article{Heiser2009,
	Abstract = {BACKGROUND: Cancer is a heterogeneous disease resulting from the accumulation of genetic defects that negatively impact control of cell division, motility, adhesion and apoptosis. Deregulation in signaling along the EgfR-MAPK pathway is common in breast cancer, though the manner in which deregulation occurs varies between both individuals and cancer subtypes.
RESULTS: We were interested in identifying subnetworks within the EgfR-MAPK pathway that are similarly deregulated across subsets of breast cancers. To that end, we mapped genomic, transcriptional and proteomic profiles for 30 breast cancer cell lines onto a curated Pathway Logic symbolic systems model of EgfR-MAPK signaling. This model was composed of 539 molecular states and 396 rules governing signaling between active states. We analyzed these models and identified several subtype-specific subnetworks, including one that suggested Pak1 is particularly important in regulating the MAPK cascade when it is over-expressed. We hypothesized that Pak1 over-expressing cell lines would have increased sensitivity to Mek inhibitors. We tested this experimentally by measuring quantitative responses of 20 breast cancer cell lines to three Mek inhibitors. We found that Pak1 over-expressing luminal breast cancer cell lines are significantly more sensitive to Mek inhibition compared to those that express Pak1 at low levels. This indicates that Pak1 over-expression may be a useful clinical marker to identify patient populations that may be sensitive to Mek inhibitors.
CONCLUSIONS: All together, our results support the utility of symbolic system biology models for identification of therapeutic approaches that will be effective against breast cancer subsets.},
	Author = {Heiser, Laura M and Wang, Nicholas J and Talcott, Carolyn L and Laderoute, Keith R and Knapp, Merrill and Guan, Yinghui and Hu, Zhi and Ziyad, Safiyyah and Weber, Barbara L and Laquerre, Sylvie and Jackson, Jeffrey R and Wooster, Richard F and Kuo, Wen Lin and Gray, Joe W and Spellman, Paul T},
	Date-Added = {2016-01-06 22:51:04 +0000},
	Date-Modified = {2016-01-06 22:51:04 +0000},
	Doi = {10.1186/gb-2009-10-3-r31},
	Journal = {Genome Biol},
	Journal-Full = {Genome biology},
	Mesh = {Breast Neoplasms; Caveolin 1; Cell Line, Tumor; Cluster Analysis; Female; Gene Expression Regulation, Neoplastic; Humans; Integrins; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Models, Biological; Protein Kinase Inhibitors; RNA, Messenger; Signal Transduction; p21-Activated Kinases},
	Number = {3},
	Pages = {R31},
	Pmc = {PMC2691002},
	Pmid = {19317917},
	Pst = {ppublish},
	Title = {Integrated analysis of breast cancer cell lines reveals unique signaling pathways},
	Volume = {10},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/gb-2009-10-3-r31}}

@article{Hattne2005,
	Abstract = {UNLABELLED: MesoRD is a tool for stochastic simulation of chemical reactions and diffusion. In particular, it is an implementation of the next subvolume method, which is an exact method to simulate the Markov process corresponding to the reaction-diffusion master equation.
AVAILABILITY: MesoRD is free software, written in C++ and licensed under the GNU general public license (GPL). MesoRD runs on Linux, Mac OS X, NetBSD, Solaris and Windows XP. It can be downloaded from http://mesord.sourceforge.net.
CONTACT: johan.elf@icm.uu.se; johan.hattne@embl-hamburg.de
SUPPLEMENTARY INFORMATION: 'MesoRD User's Guide' and other documents are available at http://mesord.sourceforge.net.},
	Author = {Hattne, Johan and Fange, David and Elf, Johan},
	Date-Added = {2016-01-06 22:50:41 +0000},
	Date-Modified = {2016-01-06 22:50:41 +0000},
	Doi = {10.1093/bioinformatics/bti431},
	Journal = {Bioinformatics},
	Journal-Full = {Bioinformatics (Oxford, England)},
	Mesh = {Algorithms; Computer Simulation; Diffusion; Models, Chemical; Models, Statistical; Software; Stochastic Processes},
	Month = {Jun},
	Number = {12},
	Pages = {2923-4},
	Pmid = {15817692},
	Pst = {ppublish},
	Title = {Stochastic reaction-diffusion simulation with MesoRD},
	Volume = {21},
	Year = {2005},
	Bdsk-Url-1 = {http://dx.doi.org/10.1093/bioinformatics/bti431}}

@article{Hasenauer2011,
	Abstract = {BACKGROUND: Most of the modeling performed in the area of systems biology aims at achieving a quantitative description of the intracellular pathways within a "typical cell". However, in many biologically important situations even clonal cell populations can show a heterogeneous response. These situations require study of cell-to-cell variability and the development of models for heterogeneous cell populations.
RESULTS: In this paper we consider cell populations in which the dynamics of every single cell is captured by a parameter dependent differential equation. Differences among cells are modeled by differences in parameters which are subject to a probability density. A novel Bayesian approach is presented to infer this probability density from population snapshot data, such as flow cytometric analysis, which do not provide single cell time series data. The presented approach can deal with sparse and noisy measurement data. Furthermore, it is appealing from an application point of view as in contrast to other methods the uncertainty of the resulting parameter distribution can directly be assessed.
CONCLUSIONS: The proposed method is evaluated using artificial experimental data from a model of the tumor necrosis factor signaling network. We demonstrate that the methods are computationally efficient and yield good estimation result even for sparse data sets.},
	Author = {Hasenauer, Jan and Waldherr, Steffen and Doszczak, Malgorzata and Radde, Nicole and Scheurich, Peter and Allg{\"o}wer, Frank},
	Date-Added = {2016-01-06 22:50:32 +0000},
	Date-Modified = {2016-01-06 22:50:32 +0000},
	Doi = {10.1186/1471-2105-12-125},
	Journal = {BMC Bioinformatics},
	Journal-Full = {BMC bioinformatics},
	Mesh = {Bayes Theorem; Cytological Techniques; Models, Biological; Regression Analysis; Signal Transduction; Tumor Necrosis Factor-alpha},
	Pages = {125},
	Pmc = {PMC3114742},
	Pmid = {21527025},
	Pst = {epublish},
	Title = {Identification of models of heterogeneous cell populations from population snapshot data},
	Volume = {12},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1186/1471-2105-12-125}}

@article{Hanahan2000,
	Author = {Hanahan, D and Weinberg, R A},
	Date-Added = {2016-01-06 22:49:56 +0000},
	Date-Modified = {2016-01-06 22:49:56 +0000},
	Journal = {Cell},
	Journal-Full = {Cell},
	Mesh = {Animals; Apoptosis; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic},
	Month = {Jan},
	Number = {1},
	Pages = {57-70},
	Pmid = {10647931},
	Pst = {ppublish},
	Title = {The hallmarks of cancer},
	Volume = {100},
	Year = {2000}}

@article{Hanahan2011,
	Abstract = {The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions. Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metabolism and evading immune destruction. In addition to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment." Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.},
	Author = {Hanahan, Douglas and Weinberg, Robert A},
	Date-Added = {2016-01-06 22:49:56 +0000},
	Date-Modified = {2016-01-06 22:49:56 +0000},
	Doi = {10.1016/j.cell.2011.02.013},
	Journal = {Cell},
	Journal-Full = {Cell},
	Mesh = {Animals; Genomic Instability; Humans; Neoplasm Invasiveness; Neoplasms; Signal Transduction; Stromal Cells},
	Month = {Mar},
	Number = {5},
	Pages = {646-74},
	Pmid = {21376230},
	Pst = {ppublish},
	Title = {Hallmarks of cancer: the next generation},
	Volume = {144},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.cell.2011.02.013}}

@article{Garraway2012,
	Abstract = {UNLABELLED: All successful cancer therapies are limited by the development of drug resistance. The increase in the understanding of the molecular and biochemical bases of drug efficacy has also facilitated studies elucidating the mechanism(s) of drug resistance. Experimental approaches that can help predict the eventual clinical drug resistance, coupled with the evolution of systematic genomic and proteomic technologies, are rapidly identifying novel resistance mechanisms. In this review, we provide a historical background on drug resistance and a framework for understanding the common ways by which cancers develop resistance to targeted therapies. We further discuss advantages and disadvantages of experimental strategies that can be used to identify drug resistance mechanism(s).
SIGNIFICANCE: Increased knowledge of drug resistance mechanisms will aid in the development of effective therapies for patients with cancer. We provide a summary of current knowledge on drug resistance mechanisms and experimental strategies to identify and study additional drug resistance pathways.},
	Author = {Garraway, Levi A and J{\"a}nne, Pasi A},
	Date-Added = {2016-01-06 22:48:17 +0000},
	Date-Modified = {2016-01-06 22:48:17 +0000},
	Doi = {10.1158/2159-8290.CD-12-0012},
	Journal = {Cancer Discov},
	Journal-Full = {Cancer discovery},
	Mesh = {Antineoplastic Agents; Drug Resistance, Neoplasm; Humans; Individualized Medicine; Neoplasms},
	Month = {Mar},
	Number = {3},
	Pages = {214-26},
	Pmid = {22585993},
	Pst = {ppublish},
	Title = {Circumventing cancer drug resistance in the era of personalized medicine},
	Volume = {2},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1158/2159-8290.CD-12-0012}}

@article{Gadkar2005,
	Abstract = {Advances in molecular biology provide an opportunity to develop detailed models of biological processes that can be used to obtain an integrated understanding of the system. However, development of useful models from the available knowledge of the system and experimental observations still remains a daunting task. In this work, a model identification strategy for complex biological networks is proposed. The approach includes a state regulator problem (SRP) that provides estimates of all the component concentrations and the reaction rates of the network using the available measurements. The full set of the estimates is utilised for model parameter identification for the network of known topology. An a priori model complexity test that indicates the feasibility of performance of the proposed algorithm is developed. Fisher information matrix (FIM) theory is used to address model identifiability issues. Two signalling pathway case studies, the caspase function in apoptosis and the MAP kinase cascade system, are considered. The MAP kinase cascade, with measurements restricted to protein complex concentrations, fails the a priori test and the SRP estimates are poor as expected. The apoptosis network structure used in this work has moderate complexity and is suitable for application of the proposed tools. Using a measurement set of seven protein concentrations, accurate estimates for all unknowns are obtained. Furthermore, the effects of measurement sampling frequency and quality of information in the measurement set on the performance of the identified model are described.},
	Author = {Gadkar, K G and Varner, J and Doyle, 3rd, F J},
	Date-Added = {2016-01-06 22:48:02 +0000},
	Date-Modified = {2016-01-06 22:48:02 +0000},
	Journal = {Syst Biol (Stevenage)},
	Journal-Full = {Systems biology},
	Mesh = {Algorithms; Cell Physiological Phenomena; Computer Simulation; Databases, Factual; Feedback; Information Storage and Retrieval; Models, Biological; Signal Transduction},
	Month = {Mar},
	Number = {1},
	Pages = {17-30},
	Pmid = {17091579},
	Pst = {ppublish},
	Title = {Model identification of signal transduction networks from data using a state regulator problem},
	Volume = {2},
	Year = {2005}}

@article{Forsten1994,
	Abstract = {T-cell proliferation is regulated by the autocrine ligand interleukin-2 (IL-2), for which these cells possess dual, low-affinity and high-affinity receptor populations. Proliferation stimulated by IL-2 is dependent upon ligand binding to p75, a component of the high-affinity receptor. As with other cells exhibiting dual receptor systems, a central question is, therefore: what is the role of the low-affinity receptor population? We apply a mathematical modeling approach to examine three alternative mechanisms that have been suggested for the role of low-affinity receptors: a ligand reservoir, a receptor reservoir, and a ligand carrier. Using model parameter values specific to the IL-2/T-cell system, we find that only the ligand carrier mechanism leads to binding of autocrine ligand to high-affinity receptors that is increased over levels found on a single, pre-formed high-affinity receptor population. With the ligand reservoir and the receptor reservoir mechanisms, the presence of the low-affinity receptors actually diminishes high-affinity receptor binding due to competition. In contrast, excess low-affinity receptors can act to enhance the level of high-affinity receptor complexes when membrane transport is included, indicating that should this mechanism be inhibited, cell response could potentially be reduced or eliminated. The ligand carrier effect is especially significant for cells expressing a large number (> 10(5) receptors/cell) low-affinity receptors, and at low cell densities (< 10(4) cells/ml). This may at least partially account for the behavior demonstrated by early phase adult T-cell leukemia cells.},
	Author = {Forsten, K E and Lauffenburger, D A},
	Date-Added = {2016-01-06 22:47:14 +0000},
	Date-Modified = {2016-01-06 22:47:14 +0000},
	Journal = {Mol Immunol},
	Journal-Full = {Molecular immunology},
	Mesh = {Biological Transport; Interleukin-2; Ligands; Models, Biological; Protein Binding; Receptors, Interleukin-2},
	Month = {Jul},
	Number = {10},
	Pages = {739-51},
	Pmid = {8035836},
	Pst = {ppublish},
	Title = {The role of low-affinity interleukin-2 receptors in autocrine ligand binding: alternative mechanisms for enhanced binding effect},
	Volume = {31},
	Year = {1994}}

@article{Ferreira2002,
	Abstract = {A nutrient-limited model for avascular cancer growth including cell proliferation, motility, and death is presented. The model qualitatively reproduces commonly observed morphologies for primary tumors, and the simulated patterns are characterized by its gyration radius, total number of cancer cells, and number of cells on tumor periphery. These very distinct morphological patterns follow Gompertz growth curves, but exhibit different scaling laws for their surfaces. Also, the simulated tumors incorporate a spatial structure composed of a central necrotic core, an inner rim of quiescent cells and a narrow outer shell of proliferating cells in agreement with biological data. Finally, our results indicate that the competition for nutrients among normal and cancer cells may be a determining factor in generating papillary tumor morphology.},
	Author = {Ferreira, Jr, S C and Martins, M L and Vilela, M J},
	Date-Added = {2016-01-06 22:46:46 +0000},
	Date-Modified = {2016-01-06 22:46:46 +0000},
	Journal = {Phys Rev E Stat Nonlin Soft Matter Phys},
	Journal-Full = {Physical review. E, Statistical, nonlinear, and soft matter physics},
	Mesh = {Animals; Biophysical Phenomena; Biophysics; Cell Death; Cell Division; Cell Movement; Computer Simulation; Growth Substances; Humans; Models, Biological; Neoplasms},
	Month = {Feb},
	Number = {2 Pt 1},
	Pages = {021907},
	Pmid = {11863563},
	Pst = {ppublish},
	Title = {Reaction-diffusion model for the growth of avascular tumor},
	Volume = {65},
	Year = {2002}}

@article{Feldman2001,
	Abstract = {The normal prostate and early-stage prostate cancers depend on androgens for growth and survival, and androgen ablation therapy causes them to regress. Cancers that are not cured by surgery eventually become androgen independent, rendering anti-androgen therapy ineffective. But how does androgen independence arise? We predict that understanding the pathways that lead to the development of androgen-independent prostate cancer will pave the way to effective therapies for these, at present, untreatable cancers.},
	Author = {Feldman, B J and Feldman, D},
	Date-Added = {2016-01-06 22:46:35 +0000},
	Date-Modified = {2016-01-06 22:46:35 +0000},
	Doi = {10.1038/35094009},
	Journal = {Nat Rev Cancer},
	Journal-Full = {Nature reviews. Cancer},
	Mesh = {Androgens; Growth Substances; Humans; Male; Mutation; Prostatic Neoplasms; Receptor Protein-Tyrosine Kinases; Receptors, Androgen},
	Month = {Oct},
	Number = {1},
	Pages = {34-45},
	Pmid = {11900250},
	Pst = {ppublish},
	Title = {The development of androgen-independent prostate cancer},
	Volume = {1},
	Year = {2001},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/35094009}}

@article{Faratian2009,
	Abstract = {Resistance to targeted cancer therapies such as trastuzumab is a frequent clinical problem not solely because of insufficient expression of HER2 receptor but also because of the overriding activation states of cell signaling pathways. Systems biology approaches lend themselves to rapid in silico testing of factors, which may confer resistance to targeted therapies. Inthis study, we aimed to develop a new kinetic model that could be interrogated to predict resistance to receptor tyrosine kinase (RTK) inhibitor therapies and directly test predictions in vitro and in clinical samples. The new mathematical model included RTK inhibitor antibody binding, HER2/HER3 dimerization and inhibition, AKT/mitogen-activated protein kinase cross-talk, and the regulatory properties of PTEN. The model was parameterized using quantitative phosphoprotein expression data from cancer cell lines using reverse-phase protein microarrays. Quantitative PTEN protein expression was found to be the key determinant of resistance to anti-HER2 therapy in silico, which was predictive of unseen experiments in vitro using the PTEN inhibitor bp(V). When measured in cancer cell lines, PTEN expression predicts sensitivity to anti-HER2 therapy; furthermore, this quantitative measurement is more predictive of response (relative risk, 3.0; 95% confidence interval, 1.6-5.5; P < 0.0001) than other pathway components taken in isolation and when tested by multivariate analysis in a cohort of 122 breast cancers treated with trastuzumab. For the first time, a systems biology approach has successfully been used to stratify patients for personalized therapy in cancer and is further compelling evidence that PTEN, appropriately measured in the clinical setting, refines clinical decision making in patients treated with anti-HER2 therapies.},
	Author = {Faratian, Dana and Goltsov, Alexey and Lebedeva, Galina and Sorokin, Anatoly and Moodie, Stuart and Mullen, Peter and Kay, Charlene and Um, In Hwa and Langdon, Simon and Goryanin, Igor and Harrison, David J},
	Date-Added = {2016-01-06 22:46:21 +0000},
	Date-Modified = {2016-01-06 22:46:21 +0000},
	Doi = {10.1158/0008-5472.CAN-09-0777},
	Journal = {Cancer Res},
	Journal-Full = {Cancer research},
	Mesh = {Adult; Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Genes, erbB-2; Humans; Individuality; Middle Aged; Models, Biological; Models, Theoretical; PTEN Phosphohydrolase; Prognosis; Systems Biology; Tumor Cells, Cultured},
	Month = {Aug},
	Number = {16},
	Pages = {6713-20},
	Pmid = {19638581},
	Pst = {ppublish},
	Title = {Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab},
	Volume = {69},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1158/0008-5472.CAN-09-0777}}

@article{Deisboeck2011,
	Abstract = {Simulating cancer behavior across multiple biological scales in space and time, i.e., multiscale cancer modeling, is increasingly being recognized as a powerful tool to refine hypotheses, focus experiments, and enable more accurate predictions. A growing number of examples illustrate the value of this approach in providing quantitative insights in the initiation, progression, and treatment of cancer. In this review, we introduce the most recent and important multiscale cancer modeling works that have successfully established a mechanistic link between different biological scales. Biophysical, biochemical, and biomechanical factors are considered in these models. We also discuss innovative, cutting-edge modeling methods that are moving predictive multiscale cancer modeling toward clinical application. Furthermore, because the development of multiscale cancer models requires a new level of collaboration among scientists from a variety of fields such as biology, medicine, physics, mathematics, engineering, and computer science, an innovative Web-based infrastructure is needed to support this growing community.},
	Author = {Deisboeck, Thomas S and Wang, Zhihui and Macklin, Paul and Cristini, Vittorio},
	Date-Added = {2016-01-06 22:45:13 +0000},
	Date-Modified = {2016-01-06 22:45:13 +0000},
	Doi = {10.1146/annurev-bioeng-071910-124729},
	Journal = {Annu Rev Biomed Eng},
	Journal-Full = {Annual review of biomedical engineering},
	Mesh = {Algorithms; Computational Biology; Computer Simulation; Disease Progression; Humans; Individualized Medicine; Models, Biological; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Receptor, Epidermal Growth Factor; Systems Biology},
	Month = {Aug},
	Pages = {127-55},
	Pmc = {PMC3883359},
	Pmid = {21529163},
	Pst = {ppublish},
	Title = {Multiscale cancer modeling},
	Volume = {13},
	Year = {2011},
	Bdsk-Url-1 = {http://dx.doi.org/10.1146/annurev-bioeng-071910-124729}}

@article{Daniels2008,
	Abstract = {The functioning of many biochemical networks is often robust-remarkably stable under changes in external conditions and internal reaction parameters. Much recent work on robustness and evolvability has focused on the structure of neutral spaces, in which system behavior remains invariant to mutations. Recently we have shown that the collective behavior of multiparameter models is most often sloppy: insensitive to changes except along a few 'stiff' combinations of parameters, with an enormous sloppy neutral subspace. Robustness is often assumed to be an emergent evolved property, but the sloppiness natural to biochemical networks offers an alternative nonadaptive explanation. Conversely, ideas developed to study evolvability in robust systems can be usefully extended to characterize sloppy systems.},
	Author = {Daniels, Bryan C and Chen, Yan-Jiun and Sethna, James P and Gutenkunst, Ryan N and Myers, Christopher R},
	Date-Added = {2016-01-06 22:44:40 +0000},
	Date-Modified = {2016-01-06 22:44:40 +0000},
	Doi = {10.1016/j.copbio.2008.06.008},
	Journal = {Curr Opin Biotechnol},
	Journal-Full = {Current opinion in biotechnology},
	Mesh = {Systems Biology},
	Month = {Aug},
	Number = {4},
	Pages = {389-95},
	Pmid = {18620054},
	Pst = {ppublish},
	Title = {Sloppiness, robustness, and evolvability in systems biology},
	Volume = {19},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.copbio.2008.06.008}}

@article{Creixell2012,
	Abstract = {Cells employ highly dynamic signaling networks to drive biological decision processes. Perturbations to these signaling networks may attract cells to new malignant signaling and phenotypic states, termed cancer network attractors, that result in cancer development. As different cancer cells reach these malignant states by accumulating different molecular alterations, uncovering these mechanisms represents a grand challenge in cancer biology. Addressing this challenge will require new systems-based strategies that capture the intrinsic properties of cancer signaling networks and provide deeper understanding of the processes by which genetic lesions perturb these networks and lead to disease phenotypes. Network biology will help circumvent fundamental obstacles in cancer treatment, such as drug resistance and metastasis, empowering personalized and tumor-specific cancer therapies.},
	Author = {Creixell, Pau and Schoof, Erwin M and Erler, Janine T and Linding, Rune},
	Date-Added = {2016-01-06 22:44:10 +0000},
	Date-Modified = {2016-01-06 22:44:10 +0000},
	Doi = {10.1038/nbt.2345},
	Journal = {Nat Biotechnol},
	Journal-Full = {Nature biotechnology},
	Mesh = {Animals; Biomedical Research; Humans; Individualized Medicine; Mice; Neoplasms; Signal Transduction; Systems Biology},
	Month = {Sep},
	Number = {9},
	Pages = {842-8},
	Pmid = {22965061},
	Pst = {ppublish},
	Title = {Navigating cancer network attractors for tumor-specific therapy},
	Volume = {30},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/nbt.2345}}

@article{Cohen2008,
	Abstract = {Why do seemingly identical cells respond differently to a drug? To address this, we studied the dynamics and variability of the protein response of human cancer cells to a chemotherapy drug, camptothecin. We present a dynamic-proteomics approach that measures the levels and locations of nearly 1000 different endogenously tagged proteins in individual living cells at high temporal resolution. All cells show rapid translocation of proteins specific to the drug mechanism, including the drug target (topoisomerase-1), and slower, wide-ranging temporal waves of protein degradation and accumulation. However, the cells differ in the behavior of a subset of proteins. We identify proteins whose dynamics differ widely between cells, in a way that corresponds to the outcomes-cell death or survival. This opens the way to understanding molecular responses to drugs in individual cells.},
	Author = {Cohen, A A and Geva-Zatorsky, N and Eden, E and Frenkel-Morgenstern, M and Issaeva, I and Sigal, A and Milo, R and Cohen-Saidon, C and Liron, Y and Kam, Z and Cohen, L and Danon, T and Perzov, N and Alon, U},
	Date-Added = {2016-01-06 22:43:38 +0000},
	Date-Modified = {2016-01-06 22:43:38 +0000},
	Doi = {10.1126/science.1160165},
	Journal = {Science},
	Journal-Full = {Science (New York, N.Y.)},
	Mesh = {Antineoplastic Agents, Phytogenic; Camptothecin; Cell Death; Cell Division; Cell Line, Tumor; Cell Nucleolus; Cell Nucleus; Cell Survival; Cytoplasm; DEAD-box RNA Helicases; DNA Damage; DNA Topoisomerases, Type I; Enzyme Inhibitors; Fluorescence; Humans; Luminescent Proteins; Lung Neoplasms; Metabolic Networks and Pathways; Oxidative Stress; Proteins; Proteome; Proteomics; Replication Protein C; Topoisomerase I Inhibitors},
	Month = {Dec},
	Number = {5907},
	Pages = {1511-6},
	Pmid = {19023046},
	Pst = {ppublish},
	Title = {Dynamic proteomics of individual cancer cells in response to a drug},
	Volume = {322},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1126/science.1160165}}

@article{Ciliberto2005,
	Abstract = {p53 is activated in response to events compromising the genetic integrity of a cell. Recent data show that p53 activity does not increase steadily with genetic damage but rather fluctuates in an oscillatory fashion. Theoretical studies suggest that oscillations can arise from a combination of positive and negative feedbacks or from a long negative feedback loop alone. Both negative and positive feedbacks are present in the p53/Mdm2 network, but it is not known what roles they play in the oscillatory response to DNA damage. We developed a mathematical model of p53 oscillations based on positive and negative feedbacks in the p53/Mdm2 network. According to the model, the system reacts to DNA damage by moving from a stable steady state into a region of stable limit cycles. Oscillations in the model are born with large amplitude, which guarantees an all-or-none response to damage. As p53 oscillates, damage is repaired and the system moves back to a stable steady state with low p53 activity. The model reproduces experimental data in quantitative detail. We suggest new experiments for dissecting the contributions of negative and positive feedbacks to the generation of oscillations.},
	Author = {Ciliberto, Andrea and Novak, B{\'e}la and Tyson, John J},
	Date-Added = {2016-01-06 22:43:22 +0000},
	Date-Modified = {2016-01-06 22:43:22 +0000},
	Journal = {Cell Cycle},
	Journal-Full = {Cell cycle (Georgetown, Tex.)},
	Mesh = {Animals; Cell Cycle; DNA Damage; Feedback, Physiological; Gene Expression Regulation; Humans; Models, Biological; Open Reading Frames; Oscillometry; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Transcription, Genetic; Tumor Suppressor Protein p53},
	Month = {Mar},
	Number = {3},
	Pages = {488-93},
	Pmid = {15725723},
	Pst = {ppublish},
	Title = {Steady states and oscillations in the p53/Mdm2 network},
	Volume = {4},
	Year = {2005}}

@article{Chen2009,
	Abstract = {The ErbB signaling pathways, which regulate diverse physiological responses such as cell survival, proliferation and motility, have been subjected to extensive molecular analysis. Nonetheless, it remains poorly understood how different ligands induce different responses and how this is affected by oncogenic mutations. To quantify signal flow through ErbB-activated pathways we have constructed, trained and analyzed a mass action model of immediate-early signaling involving ErbB1-4 receptors (EGFR, HER2/Neu2, ErbB3 and ErbB4), and the MAPK and PI3K/Akt cascades. We find that parameter sensitivity is strongly dependent on the feature (e.g. ERK or Akt activation) or condition (e.g. EGF or heregulin stimulation) under examination and that this context dependence is informative with respect to mechanisms of signal propagation. Modeling predicts log-linear amplification so that significant ERK and Akt activation is observed at ligand concentrations far below the K(d) for receptor binding. However, MAPK and Akt modules isolated from the ErbB model continue to exhibit switch-like responses. Thus, key system-wide features of ErbB signaling arise from nonlinear interaction among signaling elements, the properties of which appear quite different in context and in isolation.},
	Author = {Chen, William W and Schoeberl, Birgit and Jasper, Paul J and Niepel, Mario and Nielsen, Ulrik B and Lauffenburger, Douglas A and Sorger, Peter K},
	Date-Added = {2016-01-06 22:35:34 +0000},
	Date-Modified = {2016-01-06 22:35:34 +0000},
	Doi = {10.1038/msb.2008.74},
	Journal = {Mol Syst Biol},
	Journal-Full = {Molecular systems biology},
	Mesh = {Kinetics; MAP Kinase Signaling System; Oncogene Proteins v-erbB; Sensitivity and Specificity; Signal Transduction},
	Pages = {239},
	Pmc = {PMC2644173},
	Pmid = {19156131},
	Pst = {ppublish},
	Title = {Input-output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data},
	Volume = {5},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/msb.2008.74}}

@article{Chavali2008,
	Abstract = {The immune system is comprised of numerous components that interact with one another to give rise to phenotypic behaviors that are sometimes unexpected. Agent-based modeling (ABM) and cellular automata (CA) belong to a class of discrete mathematical approaches in which autonomous entities detect local information and act over time according to logical rules. The power of this approach lies in the emergence of behavior that arises from interactions between agents, which would otherwise be impossible to know a priori. Recent work exploring the immune system with ABM and CA has revealed novel insights into immunological processes. Here, we summarize these applications to immunology and, particularly, how ABM can help formulate hypotheses that might drive further experimental investigations of disease mechanisms.},
	Author = {Chavali, Arvind K and Gianchandani, Erwin P and Tung, Kenneth S and Lawrence, Michael B and Peirce, Shayn M and Papin, Jason A},
	Date-Added = {2016-01-06 22:33:03 +0000},
	Date-Modified = {2016-01-06 22:33:03 +0000},
	Doi = {10.1016/j.it.2008.08.006},
	Journal = {Trends Immunol},
	Journal-Full = {Trends in immunology},
	Mesh = {Animals; Cell Polarity; Computer Simulation; Humans; Immune System; Models, Immunological; Receptors, Antigen, T-Cell; T-Lymphocytes},
	Month = {Dec},
	Number = {12},
	Pages = {589-99},
	Pmid = {18964301},
	Pst = {ppublish},
	Title = {Characterizing emergent properties of immunological systems with multi-cellular rule-based computational modeling},
	Volume = {29},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.it.2008.08.006}}

@article{Chakrabarti2012,
	Abstract = {Breast cancer initiation, invasion and metastasis span multiple length and time scales. Molecular events at short length scales lead to an initial tumorigenic population, which left unchecked by immune action, acts at increasingly longer length scales until eventually the cancer cells escape from the primary tumor site. This series of events is highly complex, involving multiple cell types interacting with (and shaping) the microenvironment. Multiscale mathematical models have emerged as a powerful tool to quantitatively integrate the convective-diffusion-reaction processes occurring on the systemic scale, with the molecular signaling processes occurring on the cellular and subcellular scales. In this study, we reviewed the current state of the art in cancer modeling across multiple length scales, with an emphasis on the integration of intracellular signal transduction models with pro-tumorigenic chemical and mechanical microenvironmental cues. First, we reviewed the underlying biomolecular origin of breast cancer, with a special emphasis on angiogenesis. Then, we summarized the development of tissue engineering platforms which could provide high-fidelity ex vivo experimental models to identify and validate multiscale simulations. Lastly, we reviewed top-down and bottom-up multiscale strategies that integrate subcellular networks with the microenvironment. We present models of a variety of cancers, in addition to breast cancer specific models. Taken together, we expect as the sophistication of the simulations increase, that multiscale modeling and bottom-up agent-based models in particular will become an increasingly important platform technology for basic scientific discovery, as well as the identification and validation of potentially novel therapeutic targets.},
	Author = {Chakrabarti, Anirikh and Verbridge, Scott and Stroock, Abraham D and Fischbach, Claudia and Varner, Jeffrey D},
	Date-Added = {2016-01-06 22:32:56 +0000},
	Date-Modified = {2016-01-06 22:32:56 +0000},
	Doi = {10.1007/s10439-012-0655-8},
	Journal = {Ann Biomed Eng},
	Journal-Full = {Annals of biomedical engineering},
	Mesh = {Breast Neoplasms; Disease Progression; Female; Humans; Models, Biological; Neovascularization, Pathologic},
	Month = {Nov},
	Number = {11},
	Pages = {2488-500},
	Pmc = {PMC3868441},
	Pmid = {23008097},
	Pst = {ppublish},
	Title = {Multiscale models of breast cancer progression},
	Volume = {40},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1007/s10439-012-0655-8}}

@electronic{CancerGovClasses,
	Author = {U. S. National Institutes of Health, National Cancer Institute},
	Date-Added = {2016-01-06 22:32:40 +0000},
	Date-Modified = {2016-01-06 22:32:40 +0000},
	Lastchecked = {January 20, 2014},
	Month = {December},
	Title = {SEER Training Modules, Classification},
	Url = {http://training.seer.cancer.gov/disease/categories/classification.html},
	Year = {2013},
	Bdsk-Url-1 = {http://training.seer.cancer.gov/disease/categories/classification.html}}

@article{Borisov2009,
	Abstract = {Crosstalk mechanisms have not been studied as thoroughly as individual signaling pathways. We exploit experimental and computational approaches to reveal how a concordant interplay between the insulin and epidermal growth factor (EGF) signaling networks can potentiate mitogenic signaling. In HEK293 cells, insulin is a poor activator of the Ras/ERK (extracellular signal-regulated kinase) cascade, yet it enhances ERK activation by low EGF doses. We find that major crosstalk mechanisms that amplify ERK signaling are localized upstream of Ras and at the Ras/Raf level. Computational modeling unveils how critical network nodes, the adaptor proteins GAB1 and insulin receptor substrate (IRS), Src kinase, and phosphatase SHP2, convert insulin-induced increase in the phosphatidylinositol-3,4,5-triphosphate (PIP(3)) concentration into enhanced Ras/ERK activity. The model predicts and experiments confirm that insulin-induced amplification of mitogenic signaling is abolished by disrupting PIP(3)-mediated positive feedback via GAB1 and IRS. We demonstrate that GAB1 behaves as a non-linear amplifier of mitogenic responses and insulin endows EGF signaling with robustness to GAB1 suppression. Our results show the feasibility of using computational models to identify key target combinations and predict complex cellular responses to a mixture of external cues.},
	Author = {Borisov, Nikolay and Aksamitiene, Edita and Kiyatkin, Anatoly and Legewie, Stefan and Berkhout, Jan and Maiwald, Thomas and Kaimachnikov, Nikolai P and Timmer, Jens and Hoek, Jan B and Kholodenko, Boris N},
	Date-Added = {2016-01-06 22:31:45 +0000},
	Date-Modified = {2016-01-06 22:31:45 +0000},
	Doi = {10.1038/msb.2009.19},
	Journal = {Mol Syst Biol},
	Journal-Full = {Molecular systems biology},
	Mesh = {Adaptor Proteins, Signal Transducing; Cell Line; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Epidermal Growth Factor; GRB2 Adaptor Protein; Humans; Immunoprecipitation; Insulin; Mitogen-Activated Protein Kinases; Mitogens; Models, Biological; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Reproducibility of Results; Signal Transduction; Systems Biology; ras Proteins; src-Family Kinases},
	Pages = {256},
	Pmc = {PMC2683723},
	Pmid = {19357636},
	Pst = {ppublish},
	Title = {Systems-level interactions between insulin-EGF networks amplify mitogenic signaling},
	Volume = {5},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/msb.2009.19}}

@article{Bhalla2002,
	Abstract = {Intracellular signaling networks receive and process information to control cellular machines. The mitogen-activated protein kinase (MAPK) 1,2/protein kinase C (PKC) system is one such network that regulates many cellular machines, including the cell cycle machinery and autocrine/paracrine factor synthesizing machinery. We used a combination of computational analysis and experiments in mouse NIH-3T3 fibroblasts to understand the design principles of this controller network. We find that the growth factor-stimulated signaling network containing MAPK 1, 2/PKC can operate with one (monostable) or two (bistable) stable states. At low concentrations of MAPK phosphatase, the system exhibits bistable behavior, such that brief stimulus results in sustained MAPK activation. The MAPK-induced increase in the amounts of MAPK phosphatase eliminates the prolonged response capability and moves the network to a monostable state, in which it behaves as a proportional response system responding acutely to stimulus. Thus, the MAPK 1, 2/PKC controller network is flexibly designed, and MAPK phosphatase may be critical for this flexible response.},
	Author = {Bhalla, Upinder S and Ram, Prahlad T and Iyengar, Ravi},
	Date-Added = {2016-01-06 22:31:21 +0000},
	Date-Modified = {2016-01-06 22:31:21 +0000},
	Doi = {10.1126/science.1068873},
	Journal = {Science},
	Journal-Full = {Science (New York, N.Y.)},
	Mesh = {3T3 Cells; Adaptation, Physiological; Animals; Cell Cycle Proteins; Computer Simulation; Dose-Response Relationship, Drug; Dual Specificity Phosphatase 1; Feedback, Physiological; Immediate-Early Proteins; MAP Kinase Signaling System; Mathematics; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Models, Biological; Phospholipases A; Phosphoprotein Phosphatases; Phosphorylation; Protein Kinase C; Protein Phosphatase 1; Protein Tyrosine Phosphatases},
	Month = {Aug},
	Number = {5583},
	Pages = {1018-23},
	Pmid = {12169734},
	Pst = {ppublish},
	Title = {MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network},
	Volume = {297},
	Year = {2002},
	Bdsk-Url-1 = {http://dx.doi.org/10.1126/science.1068873}}

@article{Bailey2001,
	Author = {Bailey, J E},
	Date-Added = {2016-01-06 22:30:32 +0000},
	Date-Modified = {2016-01-06 22:30:32 +0000},
	Doi = {10.1038/89204},
	Journal = {Nat Biotechnol},
	Journal-Full = {Nature biotechnology},
	Mesh = {Animals; Biology; Biotechnology; Genome; Humans; Kinetics; Models, Biological; Models, Theoretical; Research},
	Month = {Jun},
	Number = {6},
	Pages = {503-4},
	Pmid = {11385433},
	Pst = {ppublish},
	Title = {Complex biology with no parameters},
	Volume = {19},
	Year = {2001},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/89204}}

@article{Apgar2010,
	Abstract = {Computational models are increasingly used to understand and predict complex biological phenomena. These models contain many unknown parameters, at least some of which are difficult to measure directly, and instead are estimated by fitting to time-course data. Previous work has suggested that even with precise data sets, many parameters are unknowable by trajectory measurements. We examined this question in the context of a pathway model of epidermal growth factor (EGF) and neuronal growth factor (NGF) signaling. Computationally, we examined a palette of experimental perturbations that included different doses of EGF and NGF as well as single and multiple gene knockdowns and overexpressions. While no single experiment could accurately estimate all of the parameters, experimental design methodology identified a set of five complementary experiments that could. These results suggest optimism for the prospects for calibrating even large models, that the success of parameter estimation is intimately linked to the experimental perturbations used, and that experimental design methodology is important for parameter fitting of biological models and likely for the accuracy that can be expected from them.},
	Author = {Apgar, Joshua F and Witmer, David K and White, Forest M and Tidor, Bruce},
	Date-Added = {2016-01-06 22:30:15 +0000},
	Date-Modified = {2016-01-06 22:30:15 +0000},
	Doi = {10.1039/b918098b},
	Journal = {Mol Biosyst},
	Journal-Full = {Molecular bioSystems},
	Mesh = {Epidermal Growth Factor; Gene Knockdown Techniques; Models, Theoretical; Nerve Growth Factor; Research Design; Signal Transduction; Uncertainty},
	Month = {Oct},
	Number = {10},
	Pages = {1890-900},
	Pmc = {PMC3505121},
	Pmid = {20556289},
	Pst = {ppublish},
	Title = {Sloppy models, parameter uncertainty, and the role of experimental design},
	Volume = {6},
	Year = {2010},
	Bdsk-Url-1 = {http://dx.doi.org/10.1039/b918098b}}

@article{Andasari2012,
	Abstract = {In this paper we present a multiscale, individual-based simulation environment that integrates CompuCell3D for lattice-based modelling on the cellular level and Bionetsolver for intracellular modelling. CompuCell3D or CC3D provides an implementation of the lattice-based Cellular Potts Model or CPM (also known as the Glazier-Graner-Hogeweg or GGH model) and a Monte Carlo method based on the metropolis algorithm for system evolution. The integration of CC3D for cellular systems with Bionetsolver for subcellular systems enables us to develop a multiscale mathematical model and to study the evolution of cell behaviour due to the dynamics inside of the cells, capturing aspects of cell behaviour and interaction that is not possible using continuum approaches. We then apply this multiscale modelling technique to a model of cancer growth and invasion, based on a previously published model of Ramis-Conde et al. (2008) where individual cell behaviour is driven by a molecular network describing the dynamics of E-cadherin and -catenin. In this model, which we refer to as the centre-based model, an alternative individual-based modelling technique was used, namely, a lattice-free approach. In many respects, the GGH or CPM methodology and the approach of the centre-based model have the same overall goal, that is to mimic behaviours and interactions of biological cells. Although the mathematical foundations and computational implementations of the two approaches are very different, the results of the presented simulations are compatible with each other, suggesting that by using individual-based approaches we can formulate a natural way of describing complex multi-cell, multiscale models. The ability to easily reproduce results of one modelling approach using an alternative approach is also essential from a model cross-validation standpoint and also helps to identify any modelling artefacts specific to a given computational approach.},
	Author = {Andasari, Vivi and Roper, Ryan T and Swat, Maciej H and Chaplain, Mark A J},
	Date-Added = {2016-01-06 22:30:06 +0000},
	Date-Modified = {2016-01-06 22:30:06 +0000},
	Doi = {10.1371/journal.pone.0033726},
	Journal = {PLoS One},
	Journal-Full = {PloS one},
	Mesh = {Algorithms; Animals; Cadherins; Cell Proliferation; Computer Simulation; Humans; Models, Biological; Monte Carlo Method; Neoplasm Invasiveness; Neoplasms; Spheroids, Cellular; beta Catenin},
	Number = {3},
	Pages = {e33726},
	Pmc = {PMC3312894},
	Pmid = {22461894},
	Pst = {ppublish},
	Title = {Integrating intracellular dynamics using CompuCell3D and Bionetsolver: applications to multiscale modelling of cancer cell growth and invasion},
	Volume = {7},
	Year = {2012},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pone.0033726}}

@article{Aldridge2006,
	Abstract = {Physicochemical modelling of signal transduction links fundamental chemical and physical principles, prior knowledge about regulatory pathways, and experimental data of various types to create powerful tools for formalizing and extending traditional molecular and cellular biology.},
	Author = {Aldridge, Bree B and Burke, John M and Lauffenburger, Douglas A and Sorger, Peter K},
	Date-Added = {2016-01-06 22:29:44 +0000},
	Date-Modified = {2016-01-06 22:29:44 +0000},
	Doi = {10.1038/ncb1497},
	Journal = {Nat Cell Biol},
	Journal-Full = {Nature cell biology},
	Mesh = {Algorithms; Animals; Cell Physiological Phenomena; Humans; Models, Biological; Reproducibility of Results; Signal Transduction; Systems Biology},
	Month = {Nov},
	Number = {11},
	Pages = {1195-203},
	Pmid = {17060902},
	Pst = {ppublish},
	Title = {Physicochemical modelling of cell signalling pathways},
	Volume = {8},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1038/ncb1497}}

@article{Aldridge2009,
	Abstract = {When modeling cell signaling networks, a balance must be struck between mechanistic detail and ease of interpretation. In this paper we apply a fuzzy logic framework to the analysis of a large, systematic dataset describing the dynamics of cell signaling downstream of TNF, EGF, and insulin receptors in human colon carcinoma cells. Simulations based on fuzzy logic recapitulate most features of the data and generate several predictions involving pathway crosstalk and regulation. We uncover a relationship between MK2 and ERK pathways that might account for the previously identified pro-survival influence of MK2. We also find unexpected inhibition of IKK following EGF treatment, possibly due to down-regulation of autocrine signaling. More generally, fuzzy logic models are flexible, able to incorporate qualitative and noisy data, and powerful enough to produce quantitative predictions and new biological insights about the operation of signaling networks.},
	Author = {Aldridge, Bree B and Saez-Rodriguez, Julio and Muhlich, Jeremy L and Sorger, Peter K and Lauffenburger, Douglas A},
	Date-Added = {2016-01-06 22:29:44 +0000},
	Date-Modified = {2016-01-06 22:29:44 +0000},
	Doi = {10.1371/journal.pcbi.1000340},
	Journal = {PLoS Comput Biol},
	Journal-Full = {PLoS computational biology},
	Mesh = {Cell Line, Tumor; Colonic Neoplasms; Computer Simulation; Epidermal Growth Factor; Fuzzy Logic; Humans; Models, Biological; Phosphotransferases; Receptor, Insulin; Signal Transduction; Tumor Necrosis Factor-alpha},
	Month = {Apr},
	Number = {4},
	Pages = {e1000340},
	Pmc = {PMC2663056},
	Pmid = {19343194},
	Pst = {ppublish},
	Title = {Fuzzy logic analysis of kinase pathway crosstalk in TNF/EGF/insulin-induced signaling},
	Volume = {5},
	Year = {2009},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pcbi.1000340}}

@article{Albeck2008,
	Abstract = {When exposed to tumor necrosis factor (TNF) or TNF-related apoptosis-inducing ligand (TRAIL), a closely related death ligand and investigational therapeutic, cells enter a protracted period of variable duration in which only upstream initiator caspases are active. A subsequent and sudden transition marks activation of the downstream effector caspases that rapidly dismantle the cell. Thus, extrinsic apoptosis is controlled by an unusual variable-delay, snap-action switch that enforces an unambiguous choice between life and death. To understand how the extrinsic apoptosis switch functions in quantitative terms, we constructed a mathematical model based on a mass-action representation of known reaction pathways. The model was trained against experimental data obtained by live-cell imaging, flow cytometry, and immunoblotting of cells perturbed by protein depletion and overexpression. The trained model accurately reproduces the behavior of normal and perturbed cells exposed to TRAIL, making it possible to study switching mechanisms in detail. Model analysis shows, and experiments confirm, that the duration of the delay prior to effector caspase activation is determined by initiator caspase-8 activity and the rates of other reactions lying immediately downstream of the TRAIL receptor. Sudden activation of effector caspases is achieved downstream by reactions involved in permeabilization of the mitochondrial membrane and relocalization of proteins such as Smac. We find that the pattern of interactions among Bcl-2 family members, the partitioning of Smac from its binding partner XIAP, and the mechanics of pore assembly are all critical for snap-action control.},
	Author = {Albeck, John G and Burke, John M and Spencer, Sabrina L and Lauffenburger, Douglas A and Sorger, Peter K},
	Date-Added = {2016-01-06 22:29:28 +0000},
	Date-Modified = {2016-01-06 22:29:28 +0000},
	Doi = {10.1371/journal.pbio.0060299},
	Journal = {PLoS Biol},
	Journal-Full = {PLoS biology},
	Mesh = {Apoptosis; Apoptosomes; Caspase 3; Caspase 8; Caspase 9; Caspases; Computer Simulation; Enzyme Activation; Feedback, Physiological; HeLa Cells; Humans; Mitochondrial Membranes; Models, Biological; Permeability; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha},
	Month = {Dec},
	Number = {12},
	Pages = {2831-52},
	Pmc = {PMC2592357},
	Pmid = {19053173},
	Pst = {ppublish},
	Title = {Modeling a snap-action, variable-delay switch controlling extrinsic cell death},
	Volume = {6},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1371/journal.pbio.0060299}}

@article{Albeck2008a,
	Abstract = {Apoptosis in response to TRAIL or TNF requires the activation of initiator caspases, which then activate the effector caspases that dismantle cells and cause death. However, little is known about the dynamics and regulatory logic linking initiators and effectors. Using a combination of live-cell reporters, flow cytometry, and immunoblotting, we find that initiator caspases are active during the long and variable delay that precedes mitochondrial outer membrane permeabilization (MOMP) and effector caspase activation. When combined with a mathematical model of core apoptosis pathways, experimental perturbation of regulatory links between initiator and effector caspases reveals that XIAP and proteasome-dependent degradation of effector caspases are important in restraining activity during the pre-MOMP delay. We identify conditions in which restraint is impaired, creating a physiologically indeterminate state of partial cell death with the potential to generate genomic instability. Together, these findings provide a quantitative picture of caspase regulatory networks and their failure modes.},
	Author = {Albeck, John G and Burke, John M and Aldridge, Bree B and Zhang, Mingsheng and Lauffenburger, Douglas A and Sorger, Peter K},
	Date-Added = {2016-01-06 22:29:28 +0000},
	Date-Modified = {2016-01-06 22:29:28 +0000},
	Doi = {10.1016/j.molcel.2008.02.012},
	Journal = {Mol Cell},
	Journal-Full = {Molecular cell},
	Mesh = {Apoptosis; Caspases; Enzyme Activation; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Luminescent Proteins; Mathematics; Membrane Potentials; Mitochondria; Mitochondrial Proteins; Models, Theoretical; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; RNA Interference; Recombinant Fusion Proteins; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; X-Linked Inhibitor of Apoptosis Protein},
	Month = {Apr},
	Number = {1},
	Pages = {11-25},
	Pmc = {PMC2858979},
	Pmid = {18406323},
	Pst = {ppublish},
	Title = {Quantitative analysis of pathways controlling extrinsic apoptosis in single cells},
	Volume = {30},
	Year = {2008},
	Bdsk-Url-1 = {http://dx.doi.org/10.1016/j.molcel.2008.02.012}}

@article{Abbott2006,
	Abstract = {Cancer can be viewed as the loss of cooperative cell behaviors that normally facilitate multicellularity, including the formation of tissues and organs. Hanahan and Weinberg describe the phenotypic differences between healthy and cancerous cells in an article titled "The Hallmarks of Cancer" (Cell, 100, 57-70, 2000). Here the authors propose six phenotypic changes at the cellular level as the essential hallmarks of cancer. They investigate the dynamics and interactions of these hallmarks in a model known as CancerSim. They describe how CancerSim implements the hallmarks in an agent-based simulation which can help test the hypotheses put forth by Hanahan and Weinberg. Experiments with CancerSim are described that study the interactions of cell phenotype alterations, and in particular, the likely sequences of precancerous mutations, known as pathways. The experiments show that sequencing is an important factor in tumorigenesis, as some mutations have preconditions--they are selectively advantageous only in combination with other mutations. CancerSim enables a modeler to study the dynamics of a developing tumor and simulate how progression can be altered by tuning model parameters.},
	Author = {Abbott, Robert G and Forrest, Stephanie and Pienta, Kenneth J},
	Date-Added = {2016-01-06 22:29:06 +0000},
	Date-Modified = {2016-01-06 22:29:06 +0000},
	Doi = {10.1162/artl.2006.12.4.617},
	Journal = {Artif Life},
	Journal-Full = {Artificial life},
	Mesh = {Apoptosis; Artificial Intelligence; Cell Cycle; Cell Division; Computer Simulation; Genomic Instability; Humans; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Phenotype; Signal Transduction},
	Number = {4},
	Pages = {617-34},
	Pmid = {16953788},
	Pst = {ppublish},
	Title = {Simulating the hallmarks of cancer},
	Volume = {12},
	Year = {2006},
	Bdsk-Url-1 = {http://dx.doi.org/10.1162/artl.2006.12.4.617}}
